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    ¸¡¢Ó¸ý ¸¡ôÒ 
 
 
  âÃ½Á¡ö ¿¢¨Èó¾ ¦À¡ÕÇ¡ ¦ÂíÌõ 
     âÃ¸Á¡ö ¦ÅÇ¢Â¢¦Ä¡Ç¢ Â¡É §º¡¾¢ 
  ¾¡Ã½¢Â¢ø º£Å¦ºóÐ ¾¨ÉÂÇ¢òÐî 
     º¼Ä¦ÁÛõ º¼¡ðºò¾¢ý §º¡¼ºì ÜÈ¡ö 
  Å¡Ã½Á¡ö Ó¸ò§¾¡¨É Ó¾Ä¡ ¾¡Ãõ 
     Á¾¢Â¢ÃÅ¢ ¸É§ÄÚ Áñ¼ÄòÐì ¸ôÀ¡ø  
  ¸¡Ã½Á¡ö Á¾¢ÂÓ÷¾ Óñ¼ º¢ò¾÷ 
     ¸Õò¾¢É¢ø ¿¢ýÈ¢ÄíÌõ ¸¡¢Ó¸§É ¸¡ôÒ! 
     
     -«¸ò¾¢Â÷ ¨Åò¾¢Â º¢ó¾¡Á½¢ (À¡¼ø ±ñ-1) 
 
    
 
 
 
2 
 
 
 
 
 
Introduction 
 
 
 
 
3 
 
INTRODUCTION: 
Siddha- not only for the body; 
But special for the soul. 
¸¼×û Å¡úòÐ : 
      
  ´ýÚ «Åý¾¡§É;þÃñÎ «Åý þýÉÕû; 
  ¿¢ýÈÉý ãýÈ¢Ûû; ¿¡ýÌ ¯½÷ó¾¡ý; ³óÐ 
  ¦ÅýÈÉý;¬Ú Å¢¡¢ó¾Éý; ²Ø ¯õÀ÷î 
  ¦ºýÈÉý; ¾¡ý þÕó¾¡ý;¯½÷óÐ ±ð§¼. 
        -¾¢ÕÁó¾¢Ãõ (À¡¼ø ±ñ:1) 
 
 Although modern medical system updating its scientific validation second by 
second a less bit  of attention present all over the world among traditional system of 
medicine. Nowdays, that attention becoming greater day by day and not much time need 
to equalize modern medical system in all aspects like scientific validation, documentation 
etc. And there is no exception for our siddha system to achieve most successful and 
popular .  
 The siddha medical system is one of the most famous ancient Indian medical 
system widely practiced in the Southern Regions of India, and it is part of trio-Indian 
system of medicine. The term siddha derived from the word ‘siddhi’ which means 
“perfection (or) achievement (or) Eternal bliss”. The perfection not only in the medical 
aspects and also for ‘mukthi of the soul’.  The physicians  who practicing siddha aimed to 
attain the perfection of Health in all state that is physical, psychological, and social .  
 “If you cannot be a king, be a healer”- a famous quote . 
 The siddha medicine is said to have originated from Lord shiva who revealed into 
Uma.  And the system is developed by the group of spiritual people with supernatural 
powers named as siddhars (followers of shiva). They are mainly 18 and 70,000-80,000 
totally.  
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 The performance of siddha system on body, mind and soul depends 96 basic 
principles (thathuvas) considered as  forming the Human body responsive for 
physiological function. These thathuvas are universal to all human beings in normal 
condition. And  3 Humours(thadhus) named vayu, azhal, Iyam in 96 thathuvas 
responsible for normal physiological function.If any alteration in the 3 Humours  
responsible to cause pathological statue. These 3 thadus are nourished by their respective 
elements in food. 
 The system widely explains the origin of 96 thathuvas from embryo and 
disintegration of thathuvam at death. These thathuvas (principles) consists of physical 
component of human body and also mental, intellectual components, sensory and motor 
organs and co-ordination with soul, includes 5 elements which forming basis of world 
and Human beings.  
 ÓôÀÐõ ÓôÀÐõ ÓôÀò ¾ÚÅÕõ 
 ¦ºôÀõ Á¾¢û ¯¨¼ì §¸¡Â¢Öû Å¡úÀÅ÷ 
 ¦ºôÀõ Á¾¢û ¯¨¼ì §¸¡Â¢ø º¢¨¾ó¾À¢ý 
 ´ôÀ «¨ÉÅÕõ µð¦¼Îò ¾¡÷¸§Ç. 
       -¾¢ÕÁó¾¢Ãõ (À¡¼ø ±ñ:154) 
 
 The perfection of siddha apart from medical aspects, originates from perfection of 
mankind (anima) and ends up in the perfection of soul  (samathi - means merge/ bring 
together/self realization). 
 The peculiarity of siddha medical system  which contains 3 major portion i.e., 
prevention,  Treatment, Rejuvenation. 
 Prevention aspects of siddha system not only during endemic& epidemic attacks 
and also on every seasonal changes & variations ,to produce natural immunity, through 
diet modification and the use of kalpa medicines. 
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 Treatment aspects includes Diagnosis  through  envagai thervugal(8 vital 
examines),naadi (Pulse Diagnosis), Neerkuri, Neikkuri (Urine Analysis), measuring the 
forearm using thread (mani Kadai nool) and treating and managing the Disease (which 
formed by Disorder of 3 humours) using Herbal products, inorganic substances, Animal 
products (thavara,thadhu, sangama things). 
 Rejuvenation therapy of siddha medicine (syn -kaya kalpa medicine) is always 
special for that system. Kaya Kalpa evolved from two words ,Kaya-means body, Kalpa-
stone like, together meaning of keeping the body as strong as stone to prevent from 
Diseases, aging process & death too. Kalpa medicines when taken in normal physiologic 
conditions helps to promote and restores health (pothu karpam) and  promote health in 
certain Diseased state i.e., sirappu karpam. 
  The art of living depends upon several factors including maintenance of 
heredity with healthy progeny. Healthy progeny depends upon healthy gametes from both 
male and female partners of conjugated life style. Current epidemiological evidence 
suggests that 15% of couples experience infertility in the world and half remain untreated 
and/or unresolved. The famous tamil couplet which explains importance of progeny is, 
  ÌÆÄ¢É¢Ð Â¡Æ¢É¢Ð ±ýÀ÷ ¾õÁì¸û 
  ÁÆ¨Ä¦º¡ø §¸Ç¡ ¾Å÷.   
                              - ¾¢ÕÅûÙÅ÷. 
  
  À¨¼ôÒ ÀÄÀ¨¼òÐ ÀÄ§Ã¡Î ¯ñÏõ  
  ¯¨¼¦ÀÕõ ¦ºøÅ§Ã ¬Â¢Ûõ 
  þðÎõ ¦¾¡ðÎõ ¸Å¢úóÐõ 
  ¦¿öÔ¨¼ «¡¢º¢ø ¦ÁöÀ¼ Å¢¾¢÷òÐõ 
  ÁÂìÌÛ Áì¸¨Ç þøÄ¡÷ìÌ 
  ÀÄÉ¢ø¨Ä ¾¡ý Å¡Øõ ¿¡§Ç . 
                                 - ÒÈ¿¡ëÚ 
                                      «¾¢ Å£Ã Ã¡ÁÀ¡ñÊÂý. 
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 Infertility bears a social stigma. It means failure of a couple to become parent after 
one year of successful married life. 
 In India approximately 15% of couple experience some difficulties when try 
conceive. Infertility may severely affect the couples physiological harmony, sexual life 
and social function Nowdays, the incidence of infertility is comparatively higher in 
males. 
 Male infertility is a vexing clinical problem. The incidence of male infertility 
varies in different Region. The incidence of infertility among males 40%, female 40%, 
both sex 20%. 
  In olden days,our life was in co-ordination with nature.In the recent days, Life 
style modification and Diet changes are the major cause for many health problems 
includes male sexual problems . Siddha Literatures have described many medicines for 
the treatment of male infertility and provides a very good solution to these problems. One 
such siddha medicine namely “ ISABGOL CHOORANAM” has been selected for my 
dissertation work , whose efficacy is not known.   
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    AIM AND OBJECTIVES 
AIM OF THE STUDY: 
Primary aim: 
            To assess the  safety and efficacy of the siddha  drug, Isabgol chooranam. 
Secondary aim: 
             To evaluate the effect of Isabgol chooranam to increase the sperm concentration, 
viscosity of semen  and to reduce premature ejaculation, nocturnal emission in AAN 
MALADU. 
OBJECTIVES OF THE STUDY: 
 To collect the authorised measures and review the ideas of Aan maladu in Siddha 
and modern literatures. 
 To have an idea about the relation of the disease with age,occupation,economic 
states, habits, family history and climatic conditions. 
 To expose the efficacy of siddhars diagnostic principles such as mukkutram, 
envagai thervugal, eazhu udalthadhukkal, neerkuri and neikkuri. 
 To have detailed clinical investigations. 
 To have a clinical trial on the disease “AAN MALADU” with the siddha 
medicine, “ISABGOL CHOORANAM” . 
 To evaluate , 
 Bio-Chemical analysis 
 Toxicity study [acute & subacute] 
 Pharmacological action 
 To handle the modern parameters to confirm the diagnosis and prognosis of the 
study. 
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REVIEW OF THE SIDDHA LITERATURE : 
 
 According to siddha literature & siddhars view, vindhu or sukkilam  (semen) 
is an important which is compared to Lord Shiva. Vindhu anotherwise known as 
‘Sukkilam’ is the final and important constituent of 7 thathus, which giving birth to 
embryo. Most of the siddhars told about vindhu and its importance to reach & 
merge with Lord Shiva , that is the end stage of “ATTANGA YOGAM”. 
 Although all siddhars spoken about vindhu, some of them only briefly 
explained the formation, importance, embryo formation etc . For  example, the 
famous saint THIRUMOOLAR briefly explained the formation of vindhu 
(semen),physiological importance, disadvantage of masturbation, timing for coitus, 
state of orgasm, embryo formation, determination of foetal sex by male partner , 
etc in his Thirumandhiram. Some others are Thiruvalluvar in his Gnanavettiyan , 
Bogar in his janana sagaram, Brama muni in his karukadai suththiram, karukkadai 
nigandu are well known on this topic. 
 Some of the literature views from above told books and some other books 
are given below. These literatures are just like pickles for the main dish, topic. 
 
Å¢óÐ þÂø : 
Å¢óÐ §¾¡üÈõ 
   þÃº Ó¾Ä¡É ²ú¾¡Ð ãýÈ¢ý 
   ¯¡¢Â ¾¢Éò¾¢ý ´ÕÒüÀÉ¢ §À¡ø 
   «¡¢ÂÐÇ¢ Å¢óÐÅ¡Ì §Áú ãýÈ¢ý 
   ÁÕÅ¢Â Å¢óÐ ÅÇÕõ ¸¡Âò¾¢§Ä. 
 
      -¾¢ÕÁó¾¢Ãõ 1934 
 
12 
 
 Although  7 thathus nourishing  our body after getting absorbed from 
GITract , 3 are the major things that is saaram(chyme), raktham (blood)& vinthu 
(semen). The semen seems to be a waterglobules at the hit of the grass. The sperm 
need 21 days for its full growth in our body. 
Formation of vindhu (semen) : 
 
 According to siddhars 1 drop of venner made from 80 drops of senner 
(blood). 1 drop of vindhu made from 80 drops of venner. So ,6400 drops of senner 
(blood) needed to make one drop of vindhu. 
      -Udal thathuvam page.no.176 
 
Å¢óÐ ¿¡¾ Ò½÷îº¢Â¢ý ÀÂý : 
 
   ÒÈõ «¸õ ±íÌõ ÒÌóÐ´Ç¢÷ Å¢óÐ 
   ¿¢Èõ «Ð ¦Åñ¨Á;¿¢¸ú ¿¡¾õ ¦ºõ¨Á 
   ¯È Á¸¢ú ºò¾¢ º¢ÅÀ¡¾õ ¬Ôû 
   ¾¢È¦É¡Î Å£Î «Ç¢ìÌõ ¦ºÂø ¦¸¡ñ§¼. 
 
      -¾¢ÕÁó¾¢Ãõ 1929 
 
 The colour of the semen is purely white & the colour of ovum  is red.The 
joining of the both , semen & ovum leading to , fertilization of ovum by the sperm  
to form new energy,  foetus. 
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Áí¨¸Â¨Ã Ü¼ §ÅñÊÂ ¸¡Äõ; 
 
   ¦ºöÔõ «ÇÅ¢ø , ¾¢Õ¿¡ý ÓÜ÷ò¾§Á 
   ±öÔõ ¸¨Ä,¸¡Äõ,þóÐ ÀÕ¾¢¸¡ø 
   ¨¿Ôõ þ¼òÐ µÊ,¿ý ¸¡Áëø ¦¿È¢ 
   ¦ºö¸, ÅÄõ þ¼õ ¾£÷óÐ Å¢Î¸§Å. 
 
      -¾¢ÕÁó¾¢Ãõ 1941 
Time for coitus: 
 It is noted that 6 hours before  sunrising is the apt time for sexual 
intercourse. During ejaculation it is better to maintain  our breath either in 
Idakalai/pinkalai/suzhumunai to make the purpose better. 
Å¢óÐ ´Æ¢Â¡¾ÀÊ  Ò½÷¾ø : 
 
   §Â¡¸õ «ùÅ¢óÐ ´Æ¢Â¡Å¨¸ Ò½÷óÐ  
   ¬¸õ þÃñÎõ ¸Äó¾¡Öõ ¬íÌ ¯È¡ô 
   §À¡¸õ º¢Å§À¡¸õ;§À¡¸¢ ¿ü§À¡¸Á¡õ; 
   §Á¡¸õ¦¸¼ ÓÂí ¸¡÷ ã¼÷Á¡¾÷ì§¸. 
       -¾¢ÕÁó¾¢Ãõ 1960 
 
State of orgasm : 
 And it is a kind of art & stage of yoga, that is to reach the stage of orgasm in 
female without losing a drops of semen. 
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Å¢óÐ ¿£ì¸õ Ü¼¡Ð : 
 
   Å¢òÐìÌüÚ ¯ñÀ¡ý Å¢¨Ç× «È¢Â¡¾Åý  
   Å¢òÐìÌüÚ ¯ñ½¡Áø,Å¢òÐ ÍðÎ ¯ñÀÅý 
   Å¢òÐìÌüÚ ¯ñÀ¡É¢ø , §ÅÚ «Äý ®üÈÅý 
   Å¢òÐìÌüÚ ¯ñ½¡Áø, Å¢òÐ Å¢ò¾¡ý «ý§È . 
 
        -¾¢ÕÁó¾¢Ãõ 1964 
 
 It  is important that seeding the seeds ,Instead of eating it by frying/raw ,to 
get the maximum benefits of this. Similar to that everyone should utilize the semen 
as purposeful one, without losing it unnecessarily. 
§Â¡¸¢ ¬Å¾üÌ Å¢óÐ¨Å «¼ì¸ø : 
 
   À¡÷ì¸¢ýÈ Á¡¾¨Ã À¡Ã¡Ð,«¸ýÚ §À¡ö 
   µ÷ì¸¢ýÈ ¯ûÇõ ¯Õ¸,«Æø ãðÊ 
   À¡÷ì¸¢ýÈ ¸ñ,¬¨º À¡úÀ¼,ãÄò§¾ 
   §º÷ì¸¢ýÈ §Â¡¸¢ º¢Å§Â¡¸¢ ¾¡§É. 
    
       -¾¢ÕÁó¾¢Ãõ 1937 
 
Importance of  semen in yoga : 
 It is better to leave our bad thoughts among the female persons , because it 
may lead to loss of our uyir sakthi (life source fire) which helps to reach the lord 
shiva, which is the end stage of yoga (samathi). 
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Å¢ó¾¢É¡ø À¢ÈôÒ : 
 
   ¾ó¨¾ Å¢ò¾¾¢ º¡Ãò¾¢ÄÃÅÁ¡Ô¾¢òÐ 
   ³óÐ â¾õ ¾¡¸ ¯ôÀÐ ¯Å÷ À¼÷óÐ 
   Å¢óÐ §ÁÄÀ¢ ÅÕ¾ø ¨¾ Á¡º¢ ÀíÌÉ¢Ôõ 
   Å¢óÐ Å¡Ö¾¢ò ¾¢Ä¸¢Â ¿¡¾ÓÁ¢Ð§Å. 
 
    -¾¢ÕÅûÙÅ ¿¡ÂÉ¡÷ ¨Åò¾¢Â º¢ó¾¡ÁÉ¢ 800, Àì¸õ 3 
 
Birth by semen : 
 
 According to the saint Thiruvalluvar ,The semen of male partner heps to 
form embryo  after fertilization .The embryo grows up by the influence of 5 
elements (pancha bootham). The birth of foetus should takes place in the tamil 
month named ‘Thy’ andso the fertilisation must be on the month of “maasi & 
panguni “ 
 
Íì¸¢Ä Ì½õ: 
 
   ¯ñ¨ÁÂ¡É Íì¸¢Ä ÓÀ¡Â Á¡Â¢Õó¾Ðõ 
   ¦Åñ¨ÁÂ¡¸¢ ¿£¡¢§Ä Å¢¨ÃóÐ ¿£÷ ¾¡ÉÐõ 
   ¾ñ¨ÁÂ¡É ¸¡Â§Á ¾ÕòÐÕÅ Á¡ÉÐõ  
   ¦¾ý¨ÁÂ¡É »¡É¢¸û ¦¾Ç¢óÐ¨Ãì¸ §ÅÏ§Á. 
 
     -º¢Å Å¡ì¸¢Â÷ À¡¼ø, Àì¸õ ±ñ.202 
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Property of Semen : 
 
  At the time of copulation, the semen is ejaculated. The prostatic fluid 
gives the semen a milky appearance. In the early minutes after ejaculation, the 
sperm remains immotile, possibly because of the viscosity of the coagulum. As 
the coagulum dissolves the sperm become highly motile. 
 
Íì¸¢Äò¨¾ «¼ì¸¢É¡ø ¯ñ¼¡Ìõ §¿¡ö¸û : 
 
   Íì¸¢Ä ó¾¨É «¼ì¸¢ý 
   ÍÃÓ¼É£÷ì ¸ð¼¡Ìõ 
   Àì¸Á¡ö ¨¸¸¡ø ºóÐ 
   À¡ÃÁ¡ö ÅÆ¢ þÈíÌõ 
   Á¢ì¸ Á¡÷ §¿¡Ôñ¼¡Ìõ 
   Á¢Ìó¾¢Îõ À¢Ã§Á¸ó¾¡ý 
   ¾ì¸§¾¡÷ §À¡ÐÁ¡¸¢ý 
   ¾¡¢ò¾§¾¡÷ Å¡ÔÅ¢ý Ü§È. 
     - ¯¼ø ¾òÐÅõ Àì¸õ.±ñ-337 
 If the semen is controlled against nature, it may lead to increase body 
temperatue, oliguria, joint pain in arms & legs, chest pain, spermatorrhoea, etc . 
 
Features of Decreased semen level : 
 At the time of copulation , the amount of semen ejaculation ll decrease 
with or without pain, sometimes irritation of penis & pricking pain in the scrotum.  
 
     - Noi Nadal-Noi Mudhal Nadal thirattu Part-1 
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þó¾¢¡¢Â À¡¢ð¨º: 
 
  ³Â Á¨Ä À¡ø§Á¡÷ §¾É¡î º¢Âí¸Ä¡ ¸õÁ¢¨Å¨Â 
  ¨ÂÂÁ¨Ç Â¡¾È¢óÐ ¦¸¡ûÙÅ¡ ¨ÂÂÁ¨Ç 
  Ôò¾Áò¨¾ Óý§ÉÕÉ Â¢ó¾¢¡¢Â À¡¢ð¨º 
  Ôò¾Áò¨¾ áÄ¡ ¾¨Ã§Â¡÷. 
 
    -§¾Ãý ÂÁ¸ ¦ÅñÀ¡ Àì¸ ±ñ.65 
Examine the semen : 
If the semen is, 
1. White and akin to the butter, it is excellent. 
2. White and akin to curd, it is very good. 
3. White and akin to the milk, it is good. 
4. White and akin to the butter milk, it is fair 
5. Akin to the honey in colour and consistency, it is average. 
6. Akin to the ghee in colour and weight, it is poor. 
7. Akin to the toddy is colour and weight, it is very poor. 
8. Akin to the water, it is very bad. 
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¬ñ ÁÄÎ : 
 
  "À¡ÃôÀ¡ ¦ÀñÁÄ¼¡õ ¸÷ôÀì §¸¡½¢ý 
   ÀìÌÅò¨¾ ¦º¡ø¸¢§Èý ÀñÀ¡ö §¸Ù 
  ¬ÃôÀ¡ ¬ñÁÄ§¼ Â¡ÕÁøÄ¡ Áø 
   «ôÀ§É ¦ÀñÁÄÎ Â¡ÕÁ¢ø¨Ä” . 
 
     - ¸÷ôÀì §¸¡û 
     -«¸ò¾¢Â÷ ¨Åò¾¢Â º¢øÄ¨Èì §¸¡¨Å 
     -¬òÁÃðº¡Á¢÷¾õ 
 
¬ñ ÁÄÎ Ì½õ: 
 
  À¡÷ì¸§Å ¬ñÁ¸É¢ý Å¢óÐ ¾¡Ûõ 
   À¾Á¡É ¾¢ò¾¢ôÒ Â¢øÄ¡¾¾¡Öõ 
  ²÷ì¸§Å ºÄ Á£¾¢ø Á¢¾ó¾¡Öõ 
   ±Æ¢Ä¡¸ ¯Â¢÷ôÀüÚÂ¢ Õó¾¡Öõ 
  §º÷ì¸§Å ãò¾¢Ãò¾¢ø Ñ¨Ã¾¡ý §À¡Öõ 
   ¦ºÂÄ¡É ¸ÕÅÐ×õ ¾¡¢ì¸Á¡ð¼¡. 
      - ä¸¢ ÓÉ¢ 
      -Á¸Ç¢÷ ÁÕòÐÅõ 
 
  ÜÈ¢É¡÷ ÒÕ„Õ¼ Å¢óÐ ¾¡Ûõ 
   Ì½Á¸ ¾¢ò¾¢ôÒ þøÄ¡ò¾¡Öõ 
  Á£È¢Â§¾¡÷ ºÄÁ£Ð Á¢¾ó¾¡Öõ 
   Á¢¸Å¡¸ ¯Â¢ÃüÚ þÕôÀ¾¡Öõ 
  º£È¢Â§¾¡÷ ãò¾¢Ãò¾¢ø Ñ¨Ã¾¡ý §À¡Öõ 
19 
 
   º¢ÈôÀ¡É ¸ÕÅÐ¾¡ý ¾¡¢ò¾¢¼¡Ð 
  §¾È¢Â§¾¡÷ Áí¨¸Â÷¸û ÁÄ§¼ Â¡Å¡û 
   ¦¾Ç¢Å¡É ¬ñÁÄÊý ¾ý¨Á¾¡§É. 
 
     -«¡¢¨ÅÂ÷ º¢ó¾¡Á½¢,Àì¸ ±ñ:153 
 
According to Yugi Saint & the Text ‘Arivaiyar sinthamani’ : 
 Lack of sweetness in semen 
 Buoyancy on water 
 Absence of  Virility 
 Frothy maturation 
The above told characters of semen  mainly contributes infertile man.  
 
 MALE INFERTILITY IN T.V.Sambasivam pillai  DICTIONARY : 
  The Semen in such cases will be devoid of sweetness and life and 
float on the surface of water. The urine also will be frothy. Such man is incapable 
to impregnate women. 
 
AETIOLOGY: 
 
¾¢ÕãÄ÷ ÜÚõ §¿¡ö ¸¡Ã½õ: 
 
   µ¦ÃðÎî ºýÉ¢ ¯Æñ¼Ð ¦ÀñÏìÌõ 
   Å¡¦ÃðÎ ¬ÏìÌõ Á¸ò¾¡õ Í¸ºýÉ¢  
   §¿¡¢ðÎô À¡÷ì¸¢ø ¿¢¸úó¾Ð ¦Åù§ÅÚ 
   À¡¦ÃðÎ ¦Áöîº ÀÌò¾ Ó¨ÈÀ¡§Ã. 
      -¾¢ÕãÄ÷ ¸Õì¸¢¨¼ ¨Åò¾¢Âõ 600, 
        À¡¼ø ±ñ:37 
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¦À¡Õû Å¢Çì¸õ: 
  ¦Àñ¸ÙìÌ 8 Å¨¸ ºýÉ¢Â¡Öõ,¬ñ¸ÙìÌ Í¸ ºýÉ¢ 
Ó¾ü¦¸¡ñ¼ ÀÄÅ¨¸ ºýÉ¢Â¡Öõ ¸÷ôÀõ Å¡öì¸¡Áø §À¡Ìõ. 
 
MALE INFERTILITY DUE TO INFECTIONS: 
 
¸ÕõÀÉ¢¨ºÂõ¨Á : 
 
   ¦¾¡¢ó¾¦¾¡Õ Ì½ìÌÈ¢¸û §¾¡ýÚÁôÀ¡ 
   ¾¢ÈÁ¡É ¸ÕýÀÉ¢¨º Å¢ó¨¾ì ¦¸¡øÖõ 
   À¡¢óò¦¾¡Õ ¸÷ôÀò¨¾ «Æ¢Âô ÀñÏõ 
   ÀñÀ¡¸ ÂÅ÷¸ÙìÌ À¢û¨Ç Â¢ø¨Ä 
      - «¸ò¾¢Â÷ ¨ÅÝ¡¢ áø 
      - §¿¡ö ¿¡¼ø §¿¡ö Ó¾ø ¿¡¼ø ¾¢ÃðÎ 
       ÀÌ¾¢ -2, Àì¸ ±ñ:66 
 
The complications of the karumpanisai ammai  are, 
       -Death of the sperm cells in male 
-Abortion in pregnant women 
-Produce in sterility in both men and women. 
 
MALE INFERTILITY DUE TO TRAUMATIC LESIONS: 
 
1.¸øÄ¢¨¼¸¡Äõ(«ñ¼ Å÷Áõ,À£º ¸¡Äõ)- «ÊÀÎÅ¾¡ø Å÷Á ÌÈ¢Ì½õ:  
 
 Å¢¨¾ þÃñÎõ ¸¡½¡Ð.Å¢¨¾ ²È¢ì ¸¡½ôÀÎõ.Å÷Áõ «¾¢¸Á¡É¡ø 
¬ñ ÌÈ¢ ÀÄÉüÚ §À¡Ìõ.¿£÷ À¢ÊìÌõ.Å¢¨¾ §Á§ÄÈ¢Â ÀÌ¾¢Â¢ø º¨¾ ÅÇ÷óÐ 
ãÎõ. 
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2.¯îº¢ À¾ôÒ ¸¡Äõ- «ÊÀÎÅ¾¡ø Å÷Á ÌÈ¢Ì½õ: 
 
 ¦¸¡ñ¨¼ Ì¨ÆóÐ §À¡Ìõ.Å¢óÐ ¦ÅÇ¢ôÀÎõ.Š¾¢¡¢ §À¡¸õ Ì¨ÆóÐ 
§À¡Ìõ.ºýÉ¢,º£¾õ ÅóÐ §ºÕõ. 
 
      ¬¾¡Ãõ- Å÷Áõ-108 
 
 TOPICS RELATED TO MALE INFERTILITY  IN SIDDHA LITERATURE: 
 
Íì¸¢Ä Å¡¾õ: 
 
Å¡¾Á¡ Ó¼ÖÕ¸¢ Á¢¸×õ ÅüÈ¢ 
 ÁÄãò¾¢Ãõ º¢ì¸¢§Â ¸£úÅ¢Æ¡Áø 
¿¡¾Á¡õ ¿¡ì¦¸¡ÎãìÌ ¾ýÉ¢ø 
 ÑÏì¸Á¡õ ×¾¢Ãõ¾¡ÉÕÅ¢ À¡Ôõ 
§º¾Á¡õ §ºðÎÁõ §¸¡¨ÆÔñ¼¡ï 
 ¦ºÂ¦Ä¡Î ÍÅ¡ºÁ¡õ ÂÕº¢ Ôñ¼¡ï 
Ý¾Á¡ö Íì¸¢Äó¾¡ý ÕýÉ¢ Â¡Ìï 
 Ð¡¢Â Íì¸¢Ä Å¡¾õ Ýðºó¾¡§É. 
 
    - ä¸¢ ÓÉ¢ 
    -§¿¡ö ¿¡¼ø §¿¡ö Ó¾ø ¿¡¼ø ¾¢ÃðÎ 
       ÀÌ¾¢-2, Àì¸ ±ñ:574 
 
 Emaciation, constipation, oliguria, bleeding from the nose, phlegm 
accumulation due to increased kapham, breathlessness, loss of taste. All the 
symptoms are associated with affected Sukkilam, according to Yugi. 
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Íì¸¢Ä Å¡¾õ: 
 
   Å¡Ô Å¡¾õ ¸¡üÈ¢É¢¨¼ Åó¾¡ø «ÅÂí¸û 
   À¡Ôõ¸¡ø ÅÄ¢ìÌõ ÀñÏÌ½õ- ¸¡Âò¾¢ý 
   Íì¸¢Äì ¸¡Äó¾¢Ãò¾¢ü ÐýÚ Ð¡¢¾ Á¢ýÉõ 
   Òì¸¢ ¿¢Èò¾¡Ð ¦¸ðÎô§À¡õ. 
     -«¸ò¾¢Â÷ ¨Åò¾¢Â º¢ó¾¡Á½¢ ¦ÅñÀ¡-4000 
       À¡¸õ-1.Àì¸õ-60 
Íì¸¢Ä Å¡¾õ: 
 
Íì¸¢É¢Â ÁÐÃ¦Á¡Æ¢ ´ò¾¢É¢Â Áí¨¸§Â Íì¸¢Ä Å¡¾ÁÐ §¸û 
 Í¸Á¡¢Â Íì¸¢Ä ¾¡Ð «¾¢§Ä Å¡ö× ÍÆýÈÉ§Ä ±ØõÀ¢ 
¦¾¡ì¸¢Û¼§É ×¼ø¦ÁÄ¢Ôõ ÁÄƒÄõ ¦¾¡ÐòÐ ÁÄ§Á þÚÌõ 
 ¦¾¡ìÌ þÕ ãì¸¢É¢§Ä ¿¡ìÌÅ¡Â¢É¢ø ¿¢ýÚ ¦¾¡¼Ã§Å §º¡¨Ã ÅÊÔõ 
¦¸¡ì¸¢Â¾¢§Ä ¸Àõ Òì¸¢§Â ÌÁ¢È¢Îõ §¸¡¨ÆÂÐ×§Á ÅÊÔõ 
 ÜÕÁ¸§Á ¿¢ýÚ §Ä¡¸ÁÐ ¦Åó¾ Á½ø Ì½õ Å£º¢ÂÐ §À¡ø Õº¢Â¡ö 
µìÌÁ¢É¢ Íì¸¢Äõ «É§ÄÈ¢ ÒÉø §À¡Ä¡õ µÊ º¢¾Úõ ¸Õ¸¢ 
 ´ò¾ ÓÉ¢ À¸Õõ ×¨Ã§À¡ø ¾Á¢Æ¡¸§Å  µ¾¢É¡÷ ¾Ã½¢§Â¡÷ì§¸. 
 
      - Å¡¾ §¿¡ö ¦¾¡Ì¾¢( ¿¢¾¡Éõ) 
 
§¿¡Â¢ý ¿¡Ê : 
 
   ¬¸¢Â Å¡¾Óõ Å¡Ô×õ ÜÊÊø 
   ¾¡¸¢Â ¦Åû¨Ç ¾¨¼ÂüÚ ¦Áò¾Å¡ö 
   §À¡¸¢Â §ÁÉ¢ ¦À¡ÕÁ¢ ¸Õô§ÀÚõ 
   Å¡¸¢Â ¾¡Ð ÅÆí¸¡Ð ¿‰¼§Á. 
 
     -À¾¢¦Éñ º¢ò¾÷ ¿¡Ê º¡Š¾¢Ãõ, Àì¸ ±ñ:89 
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Uyir thathukkal / Mukkutram: 
 
These are all the main three pillars which functioning the body with an equilibrium 
state. Any disturbance in that state leads to diseased condition in our body. 
The three pillars are, 
1. Vali 
2. Azhal 
3. Iyam 
 
1. Vali or Vayu: 
  Vali is not mere wind, but also that which causes motion, energy and 
sensation of every cell in the body. Vayu relates to nerve force. It is responsible for 
all movements in the mind and the body. In human body it controls the 
Gnanendriyam (sensory actions) & Kanmendriyam (motor activities) 
 
Vali generally lives in, 
Abanan, Edakalai, Kamakodi, Undhiyin Keezh Moolam, Hip region, 
Bones, Muscles, Nerves,  Joints, Skin, Hair follicles, Stools. 
 
Varieties of Vali : 
 
According to their location and functions they are classified into 10 types. 
1. Uyirkkaal (Pranan) 
2. Kezhnokkum Kaal (Abanan) 
3. Paravukaal (Viyanan) 
4. Melnokkum Kaal (Udhanan) 
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5. Nadukkaal (Samanan) 
6. Naagan 
7. Koorman 
8. Kirugaran 
9. Devadhathan 
10. Thananjeyan 
 
 
 
1.Uyirkkaal (Pranan) (Heart Centre) 
  It regulates the respiratory, cardiac and digestive system. By joining 
with pingalai it forms azhal naadi. It is responsible for bio comfusion in the body. 
 
2. Kezhnokkum Kaal (Abanan) (Mooladharam Centre) 
  It regulates the defecation, micturation, menstruation, parturition and 
ejaculation. It corresponds to the pelvic plexus and the lower part of the gut. 
 
3. Paravukaal (Viyanan) (fore head centre) 
  It spreads all over the body and all nerve endings. It regulates 
constriction and relaxation of the voluntary and involuntary muscles. The 
neurological problems were due to this Vayu. It spreads the nutrients to all over the 
body from the digested food. 
 
4. Mel Nokkumkaal (Udhanan) 
 
  It is responsible for speech, vomiting, hiccough and sneeze. 
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5. Nadukkaal (Samanan): 
  It is responsible for digestion and it spreads the nutrients to all over 
the body. Joining with suzhumuna it forms the Kaba naadi. It neutralizes the other 
four Vayus. 
 
6. Naagam: 
  It is responsible for the intelligence and derangement of this Vayu 
causes impaired memory. It helps to opening and closure of eyelids. 
 
7. Koorman: 
  This is responsible for the vision, Yawning and Lacrimal secretions. 
 
8. Kirugaran: 
  It is responsible for salivation, nasal secretion, hunger, sneeze, cough 
and concentration. 
 
 
9. Devadhathan: 
  It is responsible for laziness and anger. 
 
10. Thananjeyan: 
  It produces swelling all over the body and leaves from cranium only 
after the 3rd day after death. It is responsible for the decay of the body after death. 
 
 In Aan Maladu ,Kezhnokkum Kaal & Paravukaal affected. 
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II.Azhal: 
  This is nothing but the characteristics of fire such as burning, boiling 
and heating etc. It corresponds to the functions so thermo genesis production of 
heat necessary to maintain integrity of the human circulatory system. Azhal is 
classified into 5 types. In mainly governs enzymes & hormones. 
 
Azhal lives in: 
  Between heart & the navel, Sweat, lymph, blood, stomach, urinary 
bladder, saliva eye and skin 
 
 
  In Aan Maladu, Sathaga Pitham affected. 
Name 
 
Location 
 
Function 
 
1.Akku anal 
(Analagam) 
Stomach,Small intestine Dissolvent& Digestive 
2.Vanna eri 
(Ranjagam) 
Liver, Spleen,Stomach 
 
Colouring,Pleasing,Gratifying 
 
3.Attralangi 
(Sathagam) 
Heart 
 
Effective efficient 
 
4.Nokku Azhal 
(Alosagam) 
Eyes 
 
Seeing, consideration 
 
5.Ollolithee 
(Prasagam) 
Skin Complexion of the skin 
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Iyyam: 
  It imparts moisture. Iyam is located in samanan semen, head, tongue, 
flat, bone marrow, blood, nose, chest, nerves, brain, large intestine, eyes, stomach 
& pancreas. 
 
  Name 
 
Location 
 
                    Function 
1. Alli Iyam 
(Avalambagam) 
 
 
Lung 
 
Supports all the others 
 
2. Neerpi Iyam 
(KiIethagam) 
 
 
Stomach 
 
Moistens and nourishes the food 
 
3.Suvaikanna Iyam 
(Pothagam) 
 
 
Tongue 
 
Take care of perception 
 
4 .Niraivu Iyam 
(Tharpagam) 
 
 
Head 
 
Refrigerant effect to eyes 
 
5. Ondri Iyam 
(Santhigam) 
 
Joints 
 
Stability,Lubrication 
movementsof joint 
 
  
  In Aan Maladu, Tharpagam & Santhigam  affected. 
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Udal Kattugal : (Seven Physical Constituents) 
1.Saaram – Chyle (Plasma): 
  It is responsible for the growth & development. It keeps the individual 
in good spirit and nourishes the blood. 
  In Aan Maladu, Saaram  affected . 
 
2. Senneer – Blood: 
  Blood imparts colour to the body and nourishes the muscle for the 
ability. 
 
3. Oon – muscle: 
  Gives shape to the body. 
 
4. Kozhuppu – fat: 
  It helps in lubricating the different organs and maintains oily matter of 
the body. 
5. Enbu – bone: 
  It supports the system and responsible for the posture movement of 
the body. 
6. Moolai – Marrow: 
  It fills the bone cavity, nourishes semen and imparts strength, 
endurance and shiny appearance. 
7. Sukkilam (sperm): 
  It is responsible for the reproduction. 
 
  In Aan Maladu ,Sukkilam  affected. 
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Enn vagai Thervugl (Eight diagnostic methods in Siddha): 
 
   ¿¡Ê  À¡¢ºõ ¿¡¿¢Èõ ¦Á¡Æ¢Å¢Æ¢ 
   ÁÄõ ã¾¾¢ÃÁ¢¨Å ÁÕòÐÅÃ¡Ô¾õ 
       -§¾¨ÃÂ÷ 
      -§¿¡ö ¿¡¼ø §¿¡öÓ¾ø ¿¡¼ø ¾¢ÃðÎ 
 
 It is the unique and special method in Siddha 
  - A Compendium Of Siddha Doctrine Page:301 
‘ Envagai thervugal is the specialty of Siddha diagnosis. These are the 
instruments for the physician to diagnose disease. 
 
1. Naadi: 
The three Uyir thaadukkal felt through the pulse is called Naadi. 
 
    Naadi          Vayu     Uyir thathu   Ratio 
Edakalai       +      Abanan   - Vatham    – 1 
Pinkalai        +       Piranan   - Pitham    – ½ 
Suzhumunai +    Samanan   - Kapam    – ¼ 
Parisam: 
  Observations by touch, temperature, sensory impairments, masses, 
nodes, swelling, and texture of the skin, pain, hardness, edematous, and dullness 
shall be noted. 
Naa: 
  Signs and symptoms in the tongue are considered here. Size, 
appearance, thickness, color (pigmented, magenta) fissured (longitudinal, 
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transverse) coated, geographical patches, oral hairy leucoplakia, candida, aphthous 
ulcer, sense of taste, saliva secretion. 
Niram: 
  The color of skin is mainly considered here but also the change in 
other organs. 
 
Mozhi: 
  The change in the normal sound of voice mainly uratha oli (Valithel), 
thazhntha olli (Melithal), physiological and mental status can also be noted during 
conversation. 
 
Vizhi: Colour, warm, burning sensation, irritation, visual perception 
 
Malam: Nature, quantity, colour, odour, froth, consistency are noted. 
 
Moothiram: 
  The urine examination classified into two types. 
 
a) Neerkkuri 
 
  "Åó¾¿£÷ ¸¡¢ ±¨¼ Á½õ Ñ¨Ã ±í¸¦Äý" 
       -§¾Ãý 
       -§¿¡ö ¿¡¼ø §¿¡ö Ó¾ø ¿¡¼ø 
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Urine is to be observed for the following characters 
 Niram (color) 
 Edai (specific gravity) 
 Manam (smell) 
 Nurai (froth) 
 Enjal (deposit) 
 
 
b) Neikkuri: 
  It is an important test to assess the predominantly affected humour.  
 
  «ÕóÐ Á¡È¢ Ã¾Óõ Å¢§Ã¡¾Á¾¡ö 
   «·¸ø «Ä÷¾ø «¸¡Ä çñ ¾Å¢÷¾Æø 
  ÌüÈÇÅÕó¾¢ ×Èí¸¢ ¨Å¸¨È 
   ¬Êì¸Äºò ¾¡Å¢ §Â¸¡Ð ¦Àö 
  ¦¾¡Õ ÓÜ÷ò¾ì ¸¨ÄìÌð ÀÎ ¿£¡¢ý 
   ¿¢ÈìÌÈ¢ ¦¿öìÌÈ¢  ¿¢ÕÁ¢ò¾ø ¸¼§É. 
      - §¾Ãý 
      -§¿¡ö ¿¡¼ø §¿¡ö Ó¾ø ¿¡¼ø 
 
  On the day before the urine test one should take food, consisting of all the 
six tastes at the regular time based on one’s digestive fire; after a sound overnight sleep, 
urine should be collected in a glass ware and the test should be done before 90 minutes 
from dawn. 
  A drop of oil is dropped at the centre of urine (bowl) without any shake. It 
should be ensured that the Sunlight falls on it, but is not disturbed by the wind. A keen 
observation of the oil drop suggests the condition of the patient. If the oil drop takes the 
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shape of a snake, it indicates Vatha disease. If it spreads like a ring it indicates Pitha and 
if it stands like a pearl it indicates Kapha disease. 
  If there is a combined shape like a ring in a snake, or snake in the ring, 
snake and a pearl or a pearl in the ring, it indicates combined derangement of humors. 
  White layer starts with disturbed Azhal and eventually involves all the 
three uyir thathus-thus resulting in various patterns of oil spread in the urine surface. 
 
  
Noi Neekam (Treatment): 
  In Siddha system the main aim of treatment is not only for the removal of 
physical illness but also the mental illness. Treatment is considered with prevention and 
improvement of the general body condition (rejuvenation) also. 
 
This is said as follows 
  Kappu - Prevention 
  Neekkam - Treatment – curative 
  Niraivu - Restoration – promotive 
While treating the disease the following principles must be noted. 
 
  So it is essential to diagnosis properly to know about the etiology, the 
nature of the patient, the severity of illness, the seasons and the time of the occurrence of 
the disease. 
 
Line of Treatment: 
1. To bring the three Kutrams in equilibrium 
2. Medicine (Internal) 
3. Diet and advise 
 
33 
 
1.To bring the three Kutrams in Equilibrium: 
  Since Siddha system of medicine is based on Mukkutra theory, the 
purgation (Kalichal Maruthuvam) was given by for the vitiation of three humours. 
 
 Agasthiyar Kuzhambu 65mg was administrated at early morning as a purgative in 
the prior day of treatment. 
 
ÁÕóÐ¸û: 
   ¯û ÁÕóÐ :þºôÒ§¸¡ø ÝÃ½õ 
   «Ç×: 1 ¸¢Ã¡õ, þÕ§Å¨Ç 
   «ÛÀ¡Éõ:À¡ø 
 
YOGA AND RELAXATION THERAPY: 
 
  Yoga has been practiced in India for a number of centuries. There are 
several methods of yogic practice originating from different school of thoughts. Yogic 
exercises improve the psychological functions of the individual. If yoga is practiced daily 
it gives efficient relaxation to the mind and produce freshness to the entire psychosomatic 
apparatus to restart its work with greater vigor and strength. 
  When one practices all the three methods of yoga namely postural exercise, 
breathing exercise, meditation daily one after another remarkable results could be 
obtained to maintain a good physical and mental health. I shall deal with only such asana 
as are useful in curing ailments and maintaining good health for the male infertility. 
 
1.Sarvangasana : 
  The principle cultural benefits of sarvanga asana lie in keeping the 
endocrine glands healthy. It is stimulates the pituitary and thymus glands and keeps the 
34 
 
prostate gland healthy. This asana keeps the sex glands healthy. Sexual weakness in the 
case of male can be overcome by the practice of  asana. 
2.Sirasasanam: 
  Regular practice of sirasasanam will benefit the nervous, circulatory, 
respiratory, digestive, excretory and endocrine system. 
  Sirasasanam will prevent or give relief in neurasthenia, dyspepsia, seminal 
weakness, spermatorhoea, varicose veins. It will prevent the enlargement of prostate 
gland. 
 
3.Savasanam: 
  Savasanam is a Powerful Tranquilizer. It pacifies the body and a mind 
by eliminating muscular, Nervous, Mental and Emotional tension almost immediately. 
 
4.Bhadrasana: 
  Promotes fresh Blood supply to Urogenital organs. It will effectively 
cure Nocturnal discharges and sexual debility. 
 
5.Dhanurasana: 
  It gives a good massage to the abdomen and cures constipation and 
disorders of stomach.It activates pancreas and helps in controlling diabetes. It improves 
functions of the reproductive system in male and female.  
6.Paschimottasana: 
  Relieves dyspepsia. Strengthens urogenital system. Fat in the waist is 
reduced and body gets a good shape. Insulin secretion is stimulated. Loosens all joints. 
Relieves back pain. Improves circulation to head and neck. 
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7. Viparetha karani : 
  It has all the benefits of Shirshasana and Sarvangasana. The blood 
circulation is increased in neck, throat and head region. Brain cells receives more supply 
of oxygen. Endocrine glands are stimulated. Prevents formation of wrinkles in the face 
and increase vitality of the body.Swelling in the legs diminish. Cures Insomnia, Back 
pain, Prolapse of uterus, Diabetis  and Blood pressure etc. It is called as “Sakala Roga 
Nivarini” as it is curing all diseases. 
8.Parsva konasana :  
  Expands the chest. Knee pain, Back pain are eradicated. Nervous system is 
stimulated. Impotency is corrected. Digestion and excretion are also improved. 
11. Ardha halasana : 
  Digestion is improved.Liver, spleen, kidneys and reproductive organs are 
activated. Reduces excess fat in the abdomen.  Relieves ankle, knee and thigh pain. It is 
helpful in constipation and diabetes. 
 
MUDHRAS FOR MALE INFERTILITY : 
1.Yoga Mudra: 
  Yoga Mudra tones up the pelvic organs on account of the pressure of the 
heels on the groins. It is useful in seminal weakness. 
 
2.Aswini Mudra: 
  Aswini Mudra gives tone to the reproductive organs and Nerves and 
removes seminal insufficiency and sterility. 
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PRANAYAMA: 
 It gives a feeling of freshness, energy and lightness of body and mind. 
 Strengthens the lungs. Increases its capacity and cures the disorders. 
 Digestion is improved. 
 Excretory system is stimulated. Toxins are removed from the body. 
 Skin tone is well maintained.   
 All the endocrine glands are stimulated. 
 It makes the nervous system more energetic . 
 Pranayama  can be used for therapy.  Allergic rhinitis,sinusitis, recurrent infections 
of the upper respiratory tract, chronic headaches, migraine, peptic ulcers, anxiety 
states can be treated by many kinds of pranayama, without the need for asanas. 
 It increases concentration and helps n meditation. 
 
COOLING PRANAYAMA: 
  They are Cooling Pranayamas because of their cooling effect, and  they 
help in calming down the mind by removing the mental anxiety & tension. 
 
MEDITATION: 
  It makes the mind calm and steady.It helps us to face the battle of life. It 
kills the pain and sorrow. It is a powerful nervine tonic. It increases memory power. It 
increases social harmony. It prevents and cures all psychosomatic diseases.  It provides a 
healthy happy, long life. It gives positive attitude towards life. It increases creativity and 
alertness. It helps to fight the stress successfully and quickly. It increases will power and 
so one is able to overcome bad habits. 
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VARMA POINTS FOR MALE INERTILITY: 
 
¬ñ ÁÄÎ §¿¡öìÌ Å÷Á ÁÕòÐÅõ : 
 
1.Å÷Á ÒûÇ¢-¿ÎìÌ Å÷Áõ 
þÕôÀ¢¼õ-¦¾¡ôÒÙìÌõ,ãÄòÐìÌõ ¿ÎÅ¢ø . 
ÀÂý-¬ñ¨Á Ì¨È×, ¾¡É¡¸§Å Å¢óÐ ¦ÅÇ¢Â¡¾ø 
 
2.Å÷Á ÒûÇ¢-§Á¡¾¢Ã Å÷Áõ 
þÕôÀ¢¼õ-¦¾¡ôÒÙìÌ 6 Å¢ÃÖìÌ ¸£ú . 
ÀÂý-º¢Ú¿£÷ «¼ì¸ þÂÄ¡Áø ¦ÅÇ¢§ÂÈø,Å¢óÐ ¦ÅÇ¢§ÂÈø 
 
3.Å÷Á ÒûÇ¢-¿¡Â¢ÕôÒ Å÷Áõ 
þÕôÀ¢¼õ-þÕ ¸¡Ä¢ý Å¢ø ¦À¡Õò¾¢ø. 
ÀÂý-¬ñ¨Á Ì¨È×, «Ê ÓÐÌ ÅÄ¢ 
 
4.Å÷Á ÒûÇ¢-ãò¾¢Ã Å÷Áõ 
þÕôÀ¢¼õ-¦¾¡ôÒÙìÌ 4 Å¢ÃÖìÌ ¸£ú . 
ÀÂý-º¢Ú¿£÷ ¾¡É¡¸ ¦ÅÇ¢§ÂÈø, Å¢óÐ ¦ÅÇ¢§ÂÈø 
 
5.Å÷Á ÒûÇ¢-«¸ ¯Õ¨Ç Å¢¨º ¿ÃõÒ Å÷Áõ 
þÕôÀ¢¼õ-¦¾¡¨¼ô ¦À¡Õò¾¢ý «¸ôÀÌ¾¢Â¢ø ¬ñÌÈ¢ìÌ Àì¸Å¡ðÊø . 
ÀÂý-¬ñ¨Á Ì¨È× 
 
   ¬¾¡Ãõ- a. Å÷Á ÁÕòÐÅõ (¦À¡Ð) 
           b. Å÷Áõ-108 
         c. Å÷Á ÁÕòÐÅõ (º¢ÈôÒ) 
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DIET AND ADVISE : 
 
Diets to be added: 
 
  ¾¡Ç¢ ¿ýÓÕí¨¸ ¾¨ÆàÐ  ÇõÀº¨Ä 
  Å¡Ç¢ ÄÚ¸£¨Ã ¦¿öÅ¡÷òÐñ½¢ Ä¡Ç¢¦ÂÉ 
  Å¢ïÍÅ¡÷ §À¡¸ò¾¢ø Å£õÒ¨Ãò¾ ¦Àñ¸¦ÇøÄ¡õ 
           ¦¸ïÍÅ÷ À¢ýÅ¡í¸¢ì §¸û.  
     
     -Ì½À¡¼õ ãÄ¢¨¸ ÅÌôÒ 
Vegetarian Diet: 
 
  ¸£¨Ã -¾¡Ç¢,ÓÕí¨¸,Àº¨Ä,àÐÇõ,«Ú¸£¨Ã 
   â -Å¡¨Æ. àÐÅ¨Ç 
  ¸¡ö -ÓÕí¨¸ì¸¡ö,ÓÕí¨¸À¢ïÍ 
  ÀÆõ -§À¡¢îÍ,Á¡Ð¨Ç,¾¢Ã¡ð¨º,¿¡Åø,Á¡õÀÆõ 
  Å¢òÐì¸û-Óó¾¢¡¢,Å¡Ð¨Á,ÓÕí¨¸ 
  À¡ø ÁüÚõ À¡ø ¦À¡Õð¸û 
 
Non - Vegetarian Diet: 
 
  ÀÈ¨Å-§¸¡Æ¢,¸¡¨¼, ¦¸ª¾¡¡¢,Å¡ÉõÀ¡Ê 
  Á£ý   - Å¡¨Ç, Å¢Ä¡íÌ, Å¢È¡ø 
  þ¨Èîº¢- ¦ÅûÇ¡Î 
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Diets to be Restricted: 
 
1.¦¸¡ûÙ 
2.À¡¸ø 
3.«¸ò¾¢ 
4.ÒÇ¢ôÀ¡É À¾¡÷ò¾í¸û 
5 Á¡í¸¡ö 
6.¸¡À¢,Ë 
7.§À¡¨¾ ¦À¡Õð¸û 
 
 
Patients adviced to Follow: 
 
 À¸ø ¯Èì¸õ Ü¼¡Ð 
 À¸ø Ò½÷îº¢ Ü¼¡Ð 
 Å¡Ãõ þÕÓ¨È ±ñ¨½ö ÌÇ¢Âø 
 ãò¾Á¸Ç¢¨Ã Ò½÷¾ø Ü¼¡Ð 
 ¦Àñ¸Ç¢¼ò¾¢ø Á¡¾õ ´ÕÓ¨È ÁðÎõ Ò½÷¾ø §ÅñÎõ 
 À¢Ã¡½¡Â¡Áõ,¾¢Â¡Éõ, §Â¡¸¡ºÉ ÀÂ¢üº¢¸¨Ç §Áü¦¸¡ûÇ §ÅñÎõ 
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Modern Aspects 
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MODERN ASPECTS 
Definition: 
 
  Infertility is the state of being unable to produce offspring; in a woman it is 
an inability to conceive; in a man it is an inability to impregnate. In other words, 
Infertility primarily refers to the biological inability of a person to contribute to 
conception. Infertility may also refer to the state of a woman who is unable to carry a 
pregnancy to full term. 
  Infertility is usually defined as the inability to get pregnant after a year of 
unprotected sex. According to statistics collected by the Centers for Disease Control 
(CDC), 6.1 million women between the ages of 15 to 44 have an impaired ability to have 
children, and 2.1 million married couples are 
experiencing infertility. The statistical study also found that 9.2 million women had made 
use of infertility services at some time in their life. Quite clearly, if you and your partner 
are facing infertility, you are not alone. 
 
Infertility can be of three different Types: 
Primary Infertility: 
  When a woman has never achieved conception in her life it is known as 
Primary Infertility. 
Secondary Infertility: 
  When a woman has given birth to a child in the past but is facing 
difficulty to conceive again it is called Secondary Infertility. 
Recurrent Miscarriage: 
  Women who experience recurrent miscarriages may also receive a 
diagnosis of infertility if they experience two or more successive miscarriages. 
While miscarriage is not uncommon (occurring in up to 25% of recognized 
pregnancies), less than 5% of women will experience two miscarriages in a 
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row, and less than 1% three or more successive miscarriages. 
 
Myths regarding Infertility: 
  Take a look at some of the myths regarding infertility, and consider 
what infertility is n 1. Infertility is not limited to women. 
 Infertility affects women and men equally. According to the A.S.R.M. one-third of 
infertility cases are due to female factor infertility, one-third are due to male factor 
infertility, and the remaining third due to problems from both sides, or 
unexplained reasons. Infertility is not all in your head. 
 Infertility is a disease of the reproductive system, and is not caused by not 
“wanting” to have a baby enough. Infertility can not be imagined into being. If not 
wanting a baby was enough to cause infertility, then there would be far fewer 
unintended pregnancies in the world. 
 Infertility is not limited to unhealthy people. 
 While living a healthy lifestyle is a good place to start when trying to 
achieve pregnancy, it does not cure infertility. Poor diet, smoking, drinking, 
and STDs can threaten your fertility. 
 Infertility is not limited to older couples. 
 As we age, our ability to achieve pregnancy lowers. Fertility in women 
peaks during the late teens and 20s, after which it begins to drop, with age 35 
beginning the most rapid decline. (This is why couples age 35 and older are 
encouraged to seek help for infertility after only 6 months of trying.) However, 
infertility can and does affect men and women of all ages. 
 Infertility is not going to go away if you just “relax and go on vacation.” 
 How many times have couples coping with infertility been told, “If you just 
stop thinking about it, you’ll have a baby.” Not only is this advice incorrect, 
it’s also hurtful. Extreme stress can disrupt a woman’s menstrual cycle, but 
stress alone does not cause infertility. 
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 Ignoring infertility does not help, either. While two-thirds of couples seeking 
infertility treatments will get pregnant and have a baby eventually, couples  with 
diagnosed infertility who do not receive treatment have a 5% or less chance of 
having a baby. 
 
Etiology: 
Factors relating to male infertility include:- 
 
Pretesticular Causes: 
a) Hypothalamic disease –Isolated gonadotrophin deficiency (kallmann’s syndrome) 
b) Isolated LH deficiency (Fertile eunuch”) 
c) Isolated FSH deficiency 
d) Congenital hypogonadrotrophic syndrome 
e) Haemochromatosis 
f) Exogenous hormones (estrogen- androgen excess) 
g) Glucocorticoid excess 
h)  Hyper – and hypothyroidism 
i) Drugs, alcohol, smoking 
j) Strenuous riding (bicycle riding, horseback riding) 
 
Testicular Factors: 
 
a) Genetic defects on the Y chromosome 
b) Abnormal set of chromosomes (klinefelter syndrome) 
c) Neoplasm (seminoma) 
d) Cryptorchidism 
e) Varicocle 
f) Trauma 
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g) Hydrocele 
h) Mumps 
i) Malaria 
j) Testicular dysgenesis syndrome 
 
 
 
 
 
 
A. MALE REPRODUCTIVE SYSTEM : 
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B. INTERNAL STRUCTURE OF THE TESTIS : 
 
 
 
 
 
 
Post Testicular Causes: 
a) Vas deferens obstruction 
b) Lack of Vas deferens, often related to genetic markers for Cystic Fibrosis 
c) Infection, e.g. prostatitis 
d) Retrograde ejaculation 
e) Hypospadias 
f) Impotence 
g) Acrosomal defect/egg penetration defect 
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Anatomy of male reproductive organs: 
 
Testes: 
  The testes are the primary reproductive organs or gonads in the male. They 
are ovoid reproductive and endocrine organs responsible for sperm production. They are 
suspended in the scrotum by scrotal tissues including the dartos muscle and the spermatic 
cords. Average testicular dimensions are 4-5 cm in length, 2.5 cm in breadth and 3cm in 
anterior posterior diameter; their weight varies from 10.5- 14g. The left testis usually lies 
lower than the right testis. Each testis lies obliquely within the scrotum, its upper pole 
tilted anterio laterally and the lower posteromedially. 
The testis is invested by three coats; 
a. Tunica vaginalis 
b. Tunica albuginea 
c. Tunica vasculosa 
 
A.Tunica Vaginalis: 
  It is the lower end of the peritoneal process vaginalis, whose formation 
proceeds the decent of the fetal testis from the abdomen to the scrotum. The visceral layer 
covers all the aspect of the testis except most of the posterior aspect. The more extensive 
parietal layer reaches below the testis and ascends in front of and medial to the spermatic 
cord. The Inner surface of the tunica vaginalis has a smooth, moist mesothelium the 
potential space between its visceral and parietal layers is termed the cavity of the tunica 
vaginalis. 
 
 
 
47 
 
B.Tunica Albuginea: 
  It is a dense, bluish white covering for the testis. It is composed mainly of 
interlacing bundles of collagen fibres. It is covered externally by the visceral layer of the 
tunica vaginalis, except at the epididymal head and tail and the posterior aspect of the 
testis, where vessels and nerves enter. It covers the tunica vasculosa and, at the posterior 
borders of the testis, project in to the testicular interior as a thick, incomplete fibrous 
septum, the mediastinum testis. 
 
C.Tunica Vasculosa: 
  It contains a plexus of blood vessels and delicate loose connective tissue, 
and extend over the internal aspect of the tunica albuginea, covering the septa and 
therefore all the testicular lobules. 
 
Epididymis: 
  The epididymis lies posteriorly and slight lateral to the testis, with vas 
deferens along its medial side. It has an expanded head superiorly, a body and a tail. Its 
overall length is 6-7 cm and it consists of the single convoluted ductus epididymis formed 
by the union of the efferent ducts of the testis, which attach to the rate testis. From the tail 
the vas deferens ascends medially to the deep inguinal ring, within the spermatic cord. 
 
Testicular and Epididyamal Appendices: 
  At the Upper extremities of the testis and epididymis are two small stalked 
bodies the appendix testes and appendix epididymis. They are developmental remnants of 
the para meso nephric ducts (mullerian) ducts and meso nephrons respectively . 
 
Testicular Torsion: 
  The testis and epididymis are usually fixed to their surrounding tissues. In 
some patients this fixation may be insufficient, a condition which allows the structures to 
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twist within the tunica vaginalis. This is termed testicular torsion and normally results in 
severe scrotal pain. Fertility may be affected by an episode of torsion. 
 
Seminal Vesicles: 
  The two seminal vesicles are sacculated, contorted tubes locate between the 
bladder and rectum. Each vesicle is 5 cm long, somewhat pyramidal, the base being 
directed up and posterolaterally. Essentially the seminal vesicle is a single coiled tube 
with irregular diverticula. The coils and the diverticula are connected by the fibrous 
tissue. The diameter of the tube is 3-4 mm and its uncoiled length is 10-15cm. 
 
Vas Deferens: 
  It is a muscular tube, 45 cm long, which conveys sperm to the ejaculatory 
ducts, and its distal continuation of the epididymis, starting at the epididymal tail. At first 
it is very tortuous, but it becomes straighter, and ascends along the posterior aspect of the 
testis. From the superior pole of the testis it ascends in the posterior part of the spermatic 
cord, and traverses the inguinal canal. At the internal inguinal ring the vas deferens leaves 
the cord, curves round the lateral side of the inferior epigastric artery. It then turns back 
and inclines slightly down and obliquely across the external iliac vessels to enter the 
lesser pelvis. It crosses the ureter and bends acutely to pass anteromedially between the 
posterior surface of the bladder and upper pole of the seminal vesicle. It finally descends 
to the base of the prostate, where it joins to the duct of the seminal vesicle at an acute 
angle to form the ejaculatory duct. 
Ejaculatory Ducts The ejaculatory ducts are formed on each side by the union of the 
duct of the seminal vesicle with ampulla of the vas. Each is almost 2 cm in length, starts 
from the base of the prostate, runs anteroinferiorly between its median right or left lobes. 
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Spermatic Cord: 
  At the testis traverse the abdominal wall into the scrotum during early life, 
it carries its vessels, nerves and vas deferens with it. These meet at the deep inguinal ring 
to form the spermatic cord, which suspends the testis in the scrotum and extends from the 
deep inguinal ring to the posterior aspect of the testis. The left cord is a little longer than 
the right. Between the superficial ring and testis the cord is anterior to the rounded tendon  
of adductor longus. The spermatic cord contains the vas deferens, testicular artery and 
veins, cremastric artery and artery to the vas deferens, genital branches of the 
genitofemoral nerve, cremastric nerve and sympathetic components of the testicular 
plexus. 
 
Aberrant Ductless: 
  A narrow, blind caudal aberrant ductile often occurs usually connected with 
the caudal part of the epididymal duct or with the start of the vas deferens. 
 
Paradidymis: 
  The paradidymis is a small collection of convoluted tubules found 
anteriorly in the spermatic cord above the epididymal head. 
 
Scrotum: 
  The scrotum is a cutaneous fibro muscular sac containing the testes and 
lower parts of the spermatic cords. It hangs below the pubic symphysis between the 
anteromedial aspects of the thighs. It is divided in to right and left halves by a cutaneous 
raphe, which continues ventrally to the inferior penile surface and dorsally along the 
midline of the perineum to the anus. 
  It consists of skin, dartos muscle and external spermatic, cremastric and 
internal spermatic fasciae. The scrotal skin is thin, pigmented and often rugose. It bears 
thinly scattered, crisp hairs. It has sebaceous glands, numerous sweat glands, pigment 
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cells and nerve endings. The left side of the scrotum is usually lower because the left 
spermatic cord is longer. 
 
Penis: 
  The penis, the male copulatory organ, consists of an attached root in the 
perineum and a free, normally pendulous body which is completely enveloped in skin. 
The penile skin is remarkably thin, dark and loosely connected to the tunica albuginea. At 
the corona of the penis it is folded to form the prepuce or foreskins, which variably 
overlap the glands. The prepuce and glands penis enclose a potential cleft, the preputial  
sac and the two shallow fossae flank the frenulum. 
 
Root: 
  The root of the penis consists of three masses of erectile tissue in the 
urogenital triangle, namely the two crura and the bulb, firmly attached to the pubic arch 
and the perineal membrane respectively. The crura are the posterior regions of the 
corpora, and the bulb is the posterior and of the corpus spongiosum. 
 
Body: 
  The body of the penis contains three elongated erectile masses, capable of 
considering enlargement when engorged with blood during erection. When flaccid the 
penis is cylindrical, but when erect it is triangular with rounded angles. 
Corpora Cavernosa: 
  The corpora cavernosa of the penis form most of the body. On the urethral 
surface their combined mass has a wide median groove,adjoining the corpus spongiosum. 
 
Corpus Spongiosum: 
  The corpus spongiosum of the penis is traversed by the urethra. Near the 
end of the penis it expands in to a somewhat conical enlargement, the glans penis. 
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Reproductive and Hormonal Functions of the Male: 
  The reproductive functions of the male can be divided in to three major 
subdivisions: 
(1) Spermatogenesis 
(2) Male sexual cycle 
(3) Regulation of male reproductive functions by various hormones 
Gametogenic Functions of Testes – Spermatogenesis: 
  Spermatogenesis is the process by which the male gametes called 
spermatozoa (sperms) are formed from the primitive germ cells (spermatogonia) in the 
testis throughout the process of spermatogenesis the germ cells has cytoplasmic 
attachment with Sertoli cells. Sertoll cells supply all the necessary materials for 
spermatogenesis through the Cytoplasmic attachment. 
 
Stages of Spermatogenesis: 
  Spermatogenesis occurs in four stages : 
1. Stage of proliferation 
2. Stage of growth 
3. Stage of maturation 
4. Stage of transformation. 
1. Stage of Proliferation: 
  The spermatogonia near the basement membrane of seminiferous tubule 
are larger. Each spermatogonium contains diploid number of chromosomes (23 pairs in 
man) One member of each pair is from maternal origin and the other one from paternal 
origin .During the proliferative stage, the spermatogonia divide by mitosis without any 
change in chromosomal number.During this stage, the spermatogonia migrate along with 
sertoli cells towards the lumen of seminiferous tubule. 
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2. Stage of growth: 
  In this stage, the primary spermatocyte grows into a large cell. Apart 
from growth, there is no other change in spermatocytes during this stage 
3. Stage Maturation: 
  After reaching the full size, each primary sepermatocyte quickly 
undergoes meiotic or maturation division, which occurs in two stages. 
I. First stage – two secondary spermatocytes are formed 
II. Second stage – each secondary spermatocyte divides into two spermatids. 
 
STAGES OF SPERMATOGENESIS : 
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STRUCTURE OF HUMAN SPERMATOZOA : 
 
 
 
1. Stage of Transformation: 
  The spermatids do not divide further but transform into matured 
sepermatozoa (sperms) by a process called spermeogenesis. The changes which take 
place during maturation of sperm are, 
I. Condensation of nuclear material 
II. Formation of acrosome. Mitochondrial spiral filament and tail structure 
III. Removal of extraneous cytoplasm. 
  The matured sperms are released form sertoli cells into the lumen of 
seminiferous tubules. The process by which the sperms are released in to the lumen of 
seminiferous tubules. For the transport out of testis is called , spermination. 
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Stage of spermatogenesis- Necessary Hormones  
 
1. Stage of proliferation -FSH,Growth Hormone 
2. Stage of growth  -Testosterone,Growth Hormone 
3. Stage of maturation -Testosterone,Growth Hormone 
4. Stage of transformation -Testosterone,Estrogen 
 
 
Role of Hormones in Spermatogenesis: 
  Spermatogenesis is influenced by many hormones which act either directly 
or indirectly. The hormones necessary for spermatogenesis are, 
1. Follicle stimulating hormone(FSH) 
2. Testosterone 
3. Estrogen 
4. Luteinizing hormone (LH) 
5. Growth hormone (GH) 
6. Inhibin 
7. Activin 
 
1. FSH: 
  FSH is responsible for the intiation of spermatogenesis. It binds with Sertoli 
cells and spermatogonia and induces the proliferation of spermatogonia and induces the 
proliferation of spermatogonia. It also stimulates formation of estrogen  and androgen 
binding protein from sertoli cells. 
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2. Testosterone: 
  Testosterone is responsible for the sequences of remaining stages in 
spermatogenesis. It is also responsible for maintenance of spermatogenesis. Testosterone 
activity is largely influenced by androgen binding protein. 
 
 
3. Estrogen: 
  It is formed from testosterone in Sertoli Cells. It is necessary for 
spermeogenesis. 
4. LH: 
  LH is essential for the secretion of testosterone from Leydig cells. 
5. GH: 
  GH is essential for the general metabolic process in testis. It is also 
necessary for proliferation of spermatogonia. In pituitary dwarfs, the spermatogenesis is 
severely affected. 
6. Inhibin: 
  Inhibin is a peptide belonging to transforming growth factor family. It is 
secreted by sertoli cells. It is also secreted in females by granulose cells of ovarian 
follicles. Its secretion is stimulated by FSH and inhibited by GnRH. Inhibin plays an 
important role in the regulation of spermatogenesis by inhibiting .FSH secretion through 
feedback mechanism. 
 
7. Activin: 
  Recently the peptide called activin is also found to be secreted in gonads 
along with inhibin. The exact location of it is secretion in testis is not known clearly.  It is 
suggested that secreted by leydig cells and sertoli cells. Active has opposite actions of 
inhibin. It increases secretion of FSH and accelerates spermatogenesis. 
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Maturation of sperm in the epididymis: 
 
  After formation in the seminiferous tubules, the sperm require several days 
to pass through the 6-meter long tubule of the epididymis.sperm removed from the 
seminiferous tubules and from the early portions of the epididymis are non-motile, and 
they cannot fertilize an ovum. However after the sperm have been in epididymis for some 
18 to 24 hours they develop the capability of motility even though several inhibitory 
proteins in the epididymal fluid still prevent final motility until after ejaculation. 
 
Storage of sperm: 
  The two testes of the human adult form up to 120 million sperm each day. 
A small quantity of these can be stored in the epididymis but most are stored in the vas 
deferens. They can remain stored maintaining their fertility for at least a month. During 
this time they are kept in a deeply suppressed inactive state by multiple inhibitory 
substances in the secretions of the duct. Conversely with a high level of sexual activity 
and ejaculations storage may be no longer than a few days. After ejaculation the sperm 
become motile and they also become capable of fertilizing the ovum a process called 
maturation the sertoli cells and the epithelium of the epididymis secrete a special nutrient 
fluid that is along ejaculated with sperm. This fluid contains hormones and enzymes and 
special nutrients that are essential for sperm maturation. 
 
Physiology of the Mature Sperm: 
  The activity of sperm is greatly enhanced in a neutral and slightly alkaline 
medium as exists in the ejaculated semen but it is greatly depressed in a mildly acidic 
medium. A strong acidic medium can cause rapid death of sperm. The activity of sperm 
increases markedly with increasing temperature. Although the sperm can live for many 
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weeks in the suppressed state in the genital ducts of the testes. Life expectancy of 
ejaculated sperm in the female genital tract is only 1 to 2 days. 
 
Role of Sertoli Cells in Spermatogenesis: 
  Sertoli cells influence spermatogenesis by four ways sertoli cells: 
1. Support and nourish the germ cells. 
2. provide hormonal and other substances necessary for Spermatogenesis 
3. secrete androgen binding protein (ABP) which is essential for testosterone activity, 
particularly on spermatogenesis 
4. Release the sperms in to lumen of semiferous tubeles (Spermination) 
 
Functions of seminal vesicle secretion: 
 
Nutrition to sperms: 
  The fructose and other nutritive substances from seminal vesicles are 
utilized by sperms after being ejaculated into female genital tract. 
 
Cloting of Semen: 
  The fibrinogen from secretions of seminal vesicle is converted in to the 
coagulum as soon as semen is ejaculated. 
 
On Fertilization: 
  The prostaglandin of seminal vesicle fluid enhances the fertilization of 
ovum by the following processes: 
1. Increasing the receptive capacity of cervical mucosa for Sperms. 
2. Causing reverse peristaltic movement of uterus and fallopian tubes. This, in turn, 
increases the rate of transport of sperms in female genital tract during coitus. 
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Functions of prostatic fluid: 
Maintenance of Sperm Motility: 
  The prostatic fluid provides optimum pH for the motility of sperms. 
Generally sperms are non motile at a pH of less than 6.0. There are two factors which 
decrease the pH and motility of sperm: 
i. Metabolic end products from sperm which make the fluid in 
vas deferens acidic. 
ii. Vaginal secretions in females are highly acidic with a pH of 3.0 – 4.0 The prostatic 
secretion neutralizes the acidity and maintain a pH of 6-6.5 .At this pH the sperm become 
motile and chances of fertilization are enhanced. 
 
Lysis of Coagulum: 
  The coagulum is dissolved by fibrolysin of the prostate secretion so that the 
sperm become motile. 
Semen: 
  SEMEN is a white or grey fluid that contain spermatozoa .It is the 
collection of fluid from testis, seminal vesical, prostate and bulbourethral gland.  
Semen is discharged during sexual act and the process of discharge is called ejaculation. 
At the time of ejaculation, human semen is liquid in nature.Immediately, it coagulates 
and some time it undergoes a secondary liquefaction. 
Properties of Semen: 
  1. Specific gravity : 1.028 
  2. Volume : 2 to 6 ml/ejaculation 
3. Reaction :  
   Alkaline pH of 7.5.the alkalinity is due to the secretions   
  from prostate. 
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Composition of Semen: Semen contains 10% sperm and 90% of fluid part which is 
seminal plasma. 
 
                                Semen 
                                                  ↓ 
  ______________________________  
 ↓            ↓ 
Sperms 10%        Seminal Plasma – 90% 
               ________________________↓______                  
                   ↓                                                             ↓ 
     Products from seminal vesicles – 60%             Products from prostate gland – 30% 
  1. Ascorbic acid  6. Pepsinogen    1. Acid phosphatase          9. Zinc 
  2. Fibrinogen        7. Phosphorylcholine   2. Cholestrol            10. Spermine 
  3. Flavin           8. Prostaglandian             3. Clotting enzymes          11. Bicarbonate 
  4. Fructose              (PGE-2)    4. Fibrinolysin           12. Calcium 
  5. Inositol           9. Citrate             5. Glucose            13. Citrate 
         10. Citric acid   6. Lactate dehydrogenase 14. Sodium 
 
 
 
 
Sperm: 
  Total count of sperm is about 100 to 150 million /ml of semen. Sterility 
occurs when the sperm count falls below 20 million/ml. Though the sperm can be stored 
in the male genital tract for longer period, after ejaculation, the survival time is only 
about 24 to 48 hours at a temperature equivalent to body temperature. 
  The rate of motility of sperm in female genital tract is about 3mm/minute. 
The sperm reach the fallopian tube in about 30 to 60 minute after sexual intercourse. The 
uterine contraction during sexual act facilitates the movement of sperms. 
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Capitation of the Spermation: 
  Mature sperm, even when they are coming out of the male genital tract are 
incapable of fertilising the ovum unless the further changes or CAPITATION takes place 
for a variable period 1 to 10 hours in the female genital tract. The membrane of the sperm 
thus become progressively permeable to calcium ion that enters in abundance to initiate 
the powerful whiplash forward movement of the flagellum or tail instead of its previous 
undulating motion. Calcium has a further role to bring about further chance in the 
acrosome intracellular membrane for helping to releasing its enzyme very rapidly in 
female genital tract. 
 
The Acrosome Reaction: 
  The lytic enzyme involved in the sperm penetration are mostly located in 
the anterior sperm head ,whereas other such as acrosin are primary contained within the 
acrosome .the anterior surface of the head needs to be removed allowing liberation of 
acrosin before the sperm can be penetrate zona pellucida. Removal of this anterior 
surface of the head is the process called acrosome reaction. An oocyte is surrounded by 
three layers – cumulus oophorus and corona radiate consisting of follicular cells, and the 
Zona pellucida, rich in glycolproteins. The perivitelline space is located between the zona 
pellucida and the oocyte membrane. Sperms seem to utili two mechanisms to penetrate 
oocytes – firstly, through its lytic enzymes in the anterior head portion, especially within 
the acrosome; and secondly, through its movement of the tail. Creatinine phosphokinase 
present in the midpiece of sperm allows the phosphokinase present in the midpiece of 
sperm allows the phosphorylation of creatinine and its subsequent transfer to the 
contractile element of the tail for its motion. Thus, all three segments of the sperms play 
important roles for their movement and their movement and subsequent penetration of the 
ovum. 
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Mechanism of Erection: 
  The male erectile response is a vascular event initiated by neuronal action 
and maintained by a complex interplay between vascular and neurological, and perhaps 
humoral phenomenons resulting in cascade of events. Erection of penis in simple terms 
consists of trapping pressurised blood within the confines of a limited space provided by 
the spongy corpora cavernosa. This blood – filled spaces relax and open up, allowing free 
inflow of blood leading to expansion of the chambers pulling the tunica albuginea tight. 
The tensed tunica albuginea makes the corpora hard (resistant to indentation) and rigid 
(resistant to flexion). Secondarily, it pinches off the veins (that normally let blood leave 
the chambers) trapping blood inside and contributing to the state of engorgement .The 
valves (actually flaps), according to some experts) that control the flow of blood, 
however are opened and closed by nerves that run through the spinal cord to the brain.  
  Activation by the nervous system causes a rapid increase in the blood flow 
into the penis. During erection, as blood flows into the penis, the holes in the spongy 
tissue in the penis get filled in with it. At the same time, flaps in the veins leading out of 
the penis enlarge, cutting off the outflow. Thus, more blood flows in than out, and the 
penis are compressed from the increased pressure from the erection itself. In addition, the 
heart rate and blood pressure increase the pressure of blood into the penis increases to 
maintain its hardness. 
 
 
 
Mechanism of Ejaculation: 
  The emission phase is the first phase. It involves deposition of seminal fluid 
from the ampullary vas deferens, seminal vesicles and prostate gland into posterior 
urethra. The second phase is the expulsion phase. It involves closure of bladder neck. 
62 
 
Flowed by the rhythmic contractions of the urethra by pelvicperineal and  
bulbospongiosus muscle, and intermittent relaxation of external urethra sphincters. 
  It is believed that the neurotransmitter serotonin (5HT) plays a central role 
in modulating ejaculation. Several animal studies have demonstrated its inhibitory effect 
on ejaculation. Therefore, it is perceivged that low level of serotonin in the synaptic cleft 
in these specific areas in the brain could cause premature ejaculation. This theory is 
further supported by the proven effectiveness of selective serotonin reuptake inhibitors 
(SSRIs), which increase serotonin level in the synapse, in treating PE. Sympathatic motor 
neurons control. The emission phase of ejaculation reflex and expulsion phase is 
executed by somatic and autonomic motor neurons. These motor neurons are located in 
the thoraco lumbar and lumbo sacral spinal cord and are activated in a coordinated 
manner when sufficient sensory in a coordinated manner when sufficient sensory input to 
reach the ejaculatory threshold has entered the central nervous system. 
  Several areas in the brain, and especially the nucleus paragigantocellularis, 
have been identified to be involved in ejaculatory control. 
 
Male Sexual Hormone:  
  Male sex hormones are called the androgens. Testes secrete three 
androgens: 
1. Testosterone 
2. Dihydrotestosterone 
3. Androstenedione 
Among these three androgens, testosterone is secreted in large quantities. However, 
dihydrotestosterone is more active. 
Source of Secretion of Androgens: 
  The androgens are secreted in large quantities by testes and, by adrenal 
cortex in small quantities. 
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Testes: 
  In the testes, the androgens are secreted by the interstitial cells of leydig 
which form 20% of mass of adult testis, leydig cells are numerous in newborn male infant 
and in adult male after puberty. 
 
 
Adrenal Cortex: 
  Zona reticularis of adrenal cortex also secretes androgens called 
testosterone, androstenedione and dehydro – epiandrosterone. 
Function of Teststerone: 
  In general, testosterone is responsible for the distinguishing characters 
of masculine body. In the fetal life, the tests are stimulated by human chorionic 
gonadotropins secreted by placenta. 
Sex Differentiation in Fetus: 
  Testosterone is responsible for the sex differentiation. 
i. Mullerian duct which gives rise to female accessory sex organs such as 
vagina, uterus and fallopian tube 
ii. Wolffian duct which gives rise to male accessory sex organs such as 
epididymis, vas deferens and seminal vesicles. 
Descent of Testes: 
  Testosterone is necessary for descent of testes. Initially, testes are 
developed in the abdominal cavity and are later pushed into the scrotum through inguinal 
canal just before birth. If a male child is born with undesended testes, the condition is 
called ‘cryptorchidism’. 
 
Function of Testosterone in Adult Life: 
Testosterone has two important functions in adult, 
i. Effect on sex organs 
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ii. Effect on secondary sexual characters 
On Sex Organs: 
  Testosteron increases the size of penis, scrotum and the testes after 
puberty. 
 
 
On Secondary Sexual Characters: 
  Testosterone causes development of secondary sexual characters atpuberty, 
which distinguishes the male from the male from female. 
 
Muscular Growth: 
  One of the most important male sexual characters is the development of 
musculature after puberty. The mass of the muscle increases by about 50% is due to the 
anabolic activity of testosterone on proteins 
Bone Growth: 
  After puberty the bones grow in thickness with deposition of calcium. 
The increase in thickness is due to increase in total content of bone matrix. The increase 
in bone matrix is because of protein anabolic activity of testosterone. Testosterone causes 
broadening of shoulders and it has a specific effect on pelvis which results in, 
a) Narrowing of pelvic outlet 
b) Lengthening of pelvis 
c) The funnel like shape of pelvis 
 Pelvis in males is different from that of females,which is broad and ovoid in shape. 
Testosterone  also causes early fusion of epiphyses of long bones with shaft. 
Changes in Skin: 
  Testosterone increases the thickness of skin over the entire body surface 
and the ruggedness of subcutaneous tissue. These changes in skin are due to deposition of 
proteins in skin. 
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Hair Distribution: 
  The testosterone causes male type of distribution of hair on the body. i.e 
hair growth over the pubis, along linea alba up to umbilicus, on face, on chest and other 
parts of the body like back, in males, the pubic hair has the base of the triangle 
downwards. 
 
Change in Voice: 
  At puberty, testosterone causes hypertrophy of laryngeal muscles, the 
enlargement of larynx and lengthening and thickening of vocal cords. 
Basal Metabolic Rate: 
  At the time of adolescence and earlier part of adult BMR rises 5 – 10% 
due to anabolic effect. 
Electrolyte and Water Balance: 
  Increases sodium  reabsorption from renal tubules. Sodium retention 
increases water retention also increases. 
 
Blood: 
  After puberty mild increase in blood volume by increasing water content 
and number of RBCS 
Control of Male Sexual Functions by Hormones 
  A major share of the control of sexual functions in both male and female 
begins with secretion of gonadotropin releasing hormone (GnRH) by the hypothalamus. 
This hormone in turn stimulates the anterior pituitary gland to secrete two other 
hormones called the gonadotropic hormones. 
1. Luteinizing hormone (LH) – it is the primary stimulus for the secretion of 
testosterone by the testes. 
2. Follicle stimulating hormone (FSH) – it stimulates spermatogenesis, 
GnRH and its effects. 
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Negative Feedback Control of Testosterone: 
  Testosterone regulates its own secretion by negative feedback mechanism. 
It acts on hypothalamus and inhibits the secretion of LHRH. When LHRH secretion in 
inhibited, LH is not released from anterior pituitary resulting in stoppage of testosterone 
secretion from testes. On the other hand, when testosterone production is low, lack of 
inhibition of hypothalamus leads to secretion of testosterone through LHRH and LH. 
Abnormalities of sexual function: 
Enlargement of prostate gland : 
  Enlargement of prostate gland occurs due to: 
1. Hyperplasia of glandular structures and connectivity tissuesbenign 
(non-malignant) enlargement 
2. cancer – malignant enlargement 
 
  The benign enlargement occurs in some men after the age of 60 years of 
age due to unknown causes. The enlarged prostate stretches a urethra and obstruct urine 
out flow from the bladder the common symptoms as increase in the frequency of 
urination difficulty in urination dribbling of urine after urination, occasional renal failure. 
 Malignant enlargement of prostate gland also causes obstruction of urinary passage. 
Hypogonadism in Males: 
  Hypogonadism is a condition characterized by reduction of functional 
activity of gonads. 
Signs and Symptoms: 
  The clinical picture of male hypogonadism depends upon whether the 
testicular deficiency develops before or after puberty. 
Before Puberty: 
  The features of hypogonadism are due to extirpation of before puberty. 
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After Puberty: 
  The symptoms are due to removal of testes after puberty. 
In adult: 
  Hypogonadism caused by testicular disorder increases the gonadotropin 
Secretion and the condition called hypergonadotropic hypogonadism. 
Hypogonadism that occurs due to deficiency gonadotropin is called 
hypogonadotropic hypogonadism. 
Frohlichs Syndrome: 
  It is the disorder characterized by obesity and hypogonadism in 
adolescent boy also called adiposo genital syndrome or hypothalamic eunuchism. 
 
Effect of Temperature on Spermatogenesis: 
  Increasing the temperature of the testes can prevent spermatogenesis by 
causing degeneration of most cells of the seminiferous tubules besides the spermatogonia. 
It has often be stated that the reason the testes are located in the dangling scrotum is to 
maintain the temperature of these glands, below the internal temperature of the body, 
although usually only about 2º C below the internal temperature. On cold days scrotal 
reflexes cause the musculature of the scrotum to contract, pulling the testes close to the 
body to maintain this 2º C differential. Thus the scrotum theoretically acts as a cooling 
mechanism for the testes. 
 
 
Cryptorchidism: 
  Cryptorchidism means failure of the testis to descent from the abdomen in 
to the scrotum at or near the time of birth of a fetus. During development of them male 
fetus, the testes are derived from the genital ridges in the abdomen. However, at about 3 
weeks to 1 month before the birth of the baby, the testes normally  descent through the 
inguinal canals in to the scrotum. A testis that remains throughout the life in the 
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abdominal cavity is incapable of forming sperm. The tubular epithelium undergoes 
degeneration, leaving only the interstitial structures of the testis. 
Semen analysis: 
Collection: 
  The semen specimen should be collected in a small clean wide mouthed 
jar of 10 to 20 ml (using larger jar may cause drying of some portion, when it is 
transported to the laboratory). The container must be spotlessly clean. Masturbation (self-
stimulation) is the most preferred method. Coitus interrupts (withdrawal of penis just 
prior to ejaculation during sexual intercourse) may be used, but there is always a 
possibility of loss of the sperm rich initial portion. The container must be ideally warmed 
to the body temperature, as sperms are especially susceptible to cold. 
The slide must be warmed, as otherwise motility studies may show 
erroneous result. Masturbation can be very stressful for some men especially when they 
know their counts are low, or if they have had problems with masturbation on demand for 
semen analysis in the past. The condition of the toilet room, where the patient has to go 
for procuring the specimen, is often related to their not providing the proper 
specimen. Men failing to provide a specimen could be advised either to have female 
partners beside or to see sexually arousing pictures for helping them to provide sample. 
They can also use a mechanical vibrator to get an erection. 
  In some cases, additional assistance by using liquid paraffin helps in 
masturbation. The infertility centres should have a special private room to 
allow the patients for the masturbation on demand. 
  The semen samples must be collected after a sexual abstinence 3 to 5 
days, or at least 72 hours after the last ejaculation (no sex or masturbation). It is very 
important to keep with the chosen abstinence schedule, because variations in the time 
period between ejaculations interfere with the accuracy of test results. For up to one 
week, semen characteristics, such as volume and sperm concentration, may increase with 
each day of abstinence; but after that period, the sperm motility is usually impaired. 
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Components of Semen Analysis: 
 Sperm count 
 Motility 
 Morphology 
 Volume 
 Fructose level 
 pH 
Sperm Count: 
  Sperm count, or sperm concentration to avoid mix-up, measures the 
concentration of sperm in a man's ejaculate, distinguished from total sperm count, which 
is the sperm count multiplied with volume. Anything over 20 million sperm per milliliter 
is considered normal. Anything less is considered ‘oligospermia’. The average sperm 
count today is around 60 million per milliliter in the Western world, having decreased by 
1-2% per year from substantially higher number decades ago. 
Motility: 
  A more specified measure is motility grade, where the motility of sperm is 
divided into four different grades: 
 Grade 4: Sperm with progressive motility. These are the strongest and 
swim fast in a straight line. Sometimes it is also denoted 
motility a. 
 Grade 3: (non-linear motility): These also move forward but tend to 
travel in a curved or crooked motion. Sometimes also denoted motility b. 
 Grade 2: These have non-progressive motility because they do not 
move forward despite the fact that they move their tails. 
 Grade 1: These are immotile and fail to move at all. 
Morphology: 
i. Head - The head should be oval and smooth. 
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ii. Mid piece - the mid piece should be straight and slightly thicker than the tail. 
iii. Tail - the tail should be single, unbroken, straight and without coils. 
 
Volume: 
  The volume of the sample is measured between 1.0 mL and 6.5 mL is 
normal; WHO criteria specify that any volume greater than 2.0 mL is normal. Low 
volume may indicate partial or complete blockage of the seminal vesicles, or that the man 
was born without seminal vesicles. In clinical practice, a volume of less than 2 mL in the 
setting of infertility and absent sperm should prompt an evaluation for obstructive 
azoospermia. 
 
Fructose level: 
  The normal level of fructose in the semen is at least 3 mg/ml. WHO specify 
a normal level of 13 μmol per sample. Absence of fructose may indicate a problem with 
the seminal vesicles. 
pH: 
  The normal range of pH of the sample is 7.1-8.0; WHO criteria specify 
normal as 7.2-7.8. Acidic ejaculate (lower pH value) may indicate one or both of the 
seminal vesicles are blocked. A basic ejaculate (higher pH value) may indicate an 
infection. A pH value outside of the normal range is harmful to sperm. 
 
 
Liquefaction: 
  The liquefaction is the process when the gel formed by proteins from the 
seminal vesicles is broken up and the semen becomes more liquid. It normally takes less 
than 20 minutes for the sample to change from a thick gel into a liquid. An abnormally 
long liquefaction (more than 30 minutes) time may indicate an infection. 
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Total motile spermatozoa: 
  Total motile spermatozoa (TMS) or total motile sperm count (TMSC) is 
a combination of sperm count, motility and volume, measuring how many million sperm 
cells in an entire ejaculate are motile. Use of approximately 20 million grade 3+4 sperm 
in ICI, and 5 million ones in IUI may be an approximate recommendation. 
Others: 
  The sample is tested for white blood cells. A high level of white blood 
cells (over 1 million per milliliter) may indicate an infection. 
 
Abnormalities: 
i. Aspermia: absence of semen 
ii. Azoospermia: absence of sperm 
iii. Oligospermia: low number of sperm 
iv. Asthenozoospermia: poor sperm motility 
v. Teratozoospermia: sperm carry more morphological defects than usual. 
 
Advanced sperm fertility testes: 
Computer-assisted semen analysis (casa) 
  The new technologies such as CASA incorporate the video systems to 
measure the types and the speed of sperm motility. Normal sperms swim faster and 
straighter than the abnormal ones. The average speed of a human sperm is roughly 48 to 
96mm per second. CASA permits the measurement of additional motility parameters 
such a curvilinear velocity (VCL), straight-line velocity (VSL), linearity, and flagellar 
beat frequency. CASA Measures the parameters such as VCL, VSL and amplitude of 
lateral head (ALH). The quality of sperm movement is based on a classification system of 
0 to 4, wherein 0 represents no movement and 4 represents excellent forward progression; 
for example, a semen sample with 60% motility would be characterized as 3+ to 4.2. 
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Quality Assessment of Casa: 
  Three levels of quality assessment are generally accepted: structure, 
process and results. 
 
Sperm Clumping or Agglutination: 
  The sperms may clump head-to-head, tail-to-tail, or head-to-tail. In 
particular tail-to-tail agglutination of motile sperm is noteworthy and usually is followed 
up with Sperm Function 
Semen Culture Test: 
  In a semen culture test, the semen sample is tested for the presence of 
bacteria. Testing the bacterial sensitivity to antibiotics is mandatory if there is any 
presence of bacteria. Whether the bacteria present in the specimen are that are usually 
seen in normal semen or those of a bacterial disease, Without the evidence of 
inflammation or infection, there is no indication there is no indication for routine culture 
or antibiotic treatment in infertile men. If urine analysis is abnormal or bacterial 
prostatitis is suspected from the history or the physical examination, semen culture is 
certainly indicated. The common sexually transmitted organisms such as Chlamydia 
trachomatis, Mycoplasma hominus and Ureaplasma urealyticulum have been implicated 
in reproductive failure in animals and humans. 
 
 
 
Biochemical Tests: 
  Biochemical analysis of seminal plasma mostly provides insights into  the 
function of the accessory sex glands. The fructose content of semen (normal value -250-
400 mgm or 4-28 mmol/litre) should be routinely tested. Low fructose content (less than 
120 mgm) is often due to seminal vesiculitis, androgen deficiency or partial ejaculatory 
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duct obstruction. Its absence indicates complete obstruction either due to a congenital 
block at the level of ejaculatory duct or proximal to it like agenesis of the vas and the 
seminal vesicle or following acquired post-infective cicatrisation. 
  Almost invariably, these conditions are associated with azoospermia or 
severe oligospermia. 
  The epididymis is represented by glyceryphosphorylcholine (GPC), the 
seminal vesicles by fructose, and the prostate gland by zinc. 
Immunological Tests: 
  In the enzyme-linked immune sorbent assay (ELISA) test, the antisperm 
antibodies measuring up to 20 units/m in 32 or 64 dilutions is considered normal. 
Sperm Function Tests: 
  The sperm function tests assess the sperm’s ability to fertilize the ovum. 
There is a drawback that these tests are often not standardized adequately. 
 
Sperm Viability or Sperm Survival Test: 
  The sperm viability may be determined by two methods-Eosin Y stain 
exclusion and hypo-osmotic swelling or HOS assay. 
Bovine Cervical Mucus Test: 
  The bovine cervical mucus test is another form of testing for the ability of 
the sperms to penetrate and swim through cervical mucus. These tests to assess the 
fertilizing potential of sperms. This in vitro functional test measures the ability of 
penetration of the sperms. The end point of this assay is penetration of the ovum and 
decondensation of sperm heads. Men with sperm of low SPA score are less likely to 
achieve a spontaneous pregnancy than those with high SPA score. 
 
Sperm Chromatin Structural Assay (Scsa): 
  To measure the level of DNA fragmentation in the sperm and to help the 
diagnosis and treatment for male infertility. The sperm with high levels of DNA 
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fragmentation have a lower probability of producing a successful pregnancy. Vitamin C 
protects the sperms from endogenous oxidative DNA damage that could affect sperm 
quality and increased risk of genetic defects, particularly in population with low ascorbic 
acid (like smokers against free radical damages. 24 Studies show that a daily dose of 
1000 mg showed statistically significant improvement of sperms . 
 
The Postcoital Test (Pct): 
 It is first performed by Sims more than 125 years ago, has traditionally been a 
common way to determine cervical mucus/sperm interaction. This test evaluates sperm 
concentration and motility in an aspirate of cervical mucus at midcycle shortly after the 
couple has intercourse. Results of a normal PCT would show the presence of 20 or more 
spermatozoa per high-power field. An abnormal PCT results most commonly is 
secondary to inappropriate timing of coitus. Other causes include ASA, an ovulation, an 
abnormal hormonal milieu, female or male genital tract infections, poor semen quality, 
and male sexual dysfunction. Because this test relies heavily on factors that are beyond 
the control of the clinic, the usefulness of the PCT in infertility investigation has been 
questioned. Whereas the presence of motile spermatozoa indicates that spermatozoa can 
survive in the cervical mucus, failure to find motile spermatozoa is more difficult to 
interpret Tests that investigate the in vitro interaction between spermatozoa found in 
semen and sperm-free midcycle mucus are also clinically useful. In vitro tests, such as the 
capillary test, were introduced in an attempt to standardize the sperm-mucus penetration 
capacity. The crossed mucus-hostility assay, which uses donor spermatozoa and mucus as 
controls, is utilized to determine if it is the male or female partner who is responsible for 
poor sperm-cervical mucus interaction. Recently, a commercial assay (Penetrak test) has 
been developed using bovine cervical mucus that is similar to human cervical mucus both 
biochemically and physiologically. However, this assay does not assess the female 
component of the cervical factor. The Tru-Trax Assay (Humagen) combines both 
approaches, placing human and bovine cervical mucus in adjacent walls. There is also 
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disagreement of whether these assays correlate with one another, with motility and other 
semen variables. It is likely that the cervical mucus penetration test measures a sperm 
function that is independent of other sperm functions measured. 
 
Sperm Penetration Assay (Spa): 
 
  The SPA was developed to measure the functional properties of sperm and 
was initially developed following the observation that, upon the removal of the zona 
pellucida of hamster ova, the species specificity of fertilization and the block to 
polyspermy are lost. In particular, heterologous penetrations between hamster ova and 
sperm from a variety of species, including humans, has been observed. Ideally, human 
ova should be used for this assay, but they are not widely available, and there are ethical 
problems associated with their use. Therefore, hamster ova have provided a useful model 
for the measurement of human sperm function. 
  For fertilization to occur in vivo, the sperm must first be capacitated and 
have undergone the acrosome reaction. The physiology of sperm capacitation is not 
clearly defined. In particular, it is not known whether capacitated sperm that have gained 
the ability to penetrate human ova have undergone the acrosome reaction, or whether this 
occurs as a local event at the time of gamete fusion. 
  The use of SPA as a measure of potential fertility is based on the theory 
that fertile sperm samples will either penetrate most hamster ova or result in a significant 
amount of polyspermy of the penetrated ova. Infertile sperm samples are expected to 
penetrate a lower percentage of ova or result in a lesser degree of polyspermy. 
  Consideration should be given to obtaining the SPA in couples with 
unexplained infertility or in couples in whom the decision is being made to precede with 
intrauterine insemination (IUI) or IVF, since lower SPA results have been predictive of 
poor success with IVF and lower pregnancy rates in couples attempting conception 
through intercourse. 
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Reactive Oxygen Species (Ros) Assay: 
  For cells living under aerobic conditions, oxygen represents a paradox: 
While it is required for survival and normal function, its metabolites can be potentially 
toxic due to the generation of oxygen-free radicals. Some of these metabolites, called 
ROS, have been shown to be produced by spermatozoa and to generate toxic effects on 
sperm function. However, when produced at the right time and amount, these ROS can 
also initiate and promote normal physiologic reactions such as sperm hyperactivation and 
capacitation. In human semen, high ROS formation was detected in 40% of semen 
samples from an unselected population of men consulting an infertility clinic. 
 
Nutrition: 
 
Zinc: 
  Zinc is the most important nutrient mineral influencing male fertility. Zinc 
level in the seminal plasma is directly related to sperm motility. Dietary zinc restriction 
reduces both sperm count and seminal plasma volume. Zinc levels in seminal plasma of 
normal, oligospermic, asthenospermic and azoospermic subjects show that a linear direct 
relationship seems to exist between zinc in seminal plasma and motility of spermatozoa. 
Dietary restriction of zinc can affect testicular function adversely. This is the effect of 
zinc deficiency. The serum testosterone concentration and seminal volume are most 
sensitive to zinc depletion in men in the reproductive period. 
 
 
Vitamin B 12: 
  Vitamin B 12 deficiency also plays a role in fertility. “Intrinsic factor” is 
necessary for the proper absorption of B12 and its deficiency is one of the causes of 
secondary infertility in male. 
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Vitamin C : 
  Studies have shown the concentration of ascorbic acid in seminal plasma 
directly reflects dietary intake, and lower levels of vitamin C may lead to infertility and 
increased damage to the sperm’s genetic material.36 Fraga et al demonstrated this by 
reducing ascorbic acid intake in healthy men from 250 mg to 5 mg per day. Seminal 
plasma levels of vitamin C decreased by 50 percent, with a concomitant 91-percent 
increase in sperm with DNA damage 
 
L-arginine: 
  The biochemical and physiological relevance of L-arginine lies in its role as 
the precursor in the synthesis of polyamines and testosterone. The polyamines 
putrescence and spermidine are organic components important to sperm motility.  
Arginine metabolisms is a factor in normal sperm production being involved as a source 
of nitric oxide within spermatozoa. Nitric oxide (at endogenous concentrations) appears 
to be necessary for adequate sperm motility. The endothelial (eNOS) and brain (b NOS) 
nitric oxide syntheses are abundant in normozoospermic samples but is low in 
asthenozoospermic patients. Consequently, an adequate dietary amount of Larginine is 
necessary for normal spermatogenesis, especially for the sperm motility and arginine 
aspartate (9 g daily) has been found to be effective in some cases of asthenospermia. L-
arginine, 4 gm daily has been shown to improve sperm counts in men with oligospermia. 
Nuts, oilseeds, flesh foods, pulses and legumes are common sources of L-arginine. 
 
Vitamin E: 
  The membranes of the germ cells and spermatozoa are very sensitive to 
oxidation because of their high content of PUFA (Polyunsturated fatty acids).Vitamin E 
is a major lipophilic chain-breaking anti oxidant, which protects tissue PUFA against 
peroxidation, a property that is beneficial in the male reproductive physiology. Oral 
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administration of vitamin E significantly improves the in vitro function of human 
spermatozoa as assessed by the zonabinding test. Vitamin E antioxidant therapy is 
however, dependent on the dosage or the in vitro concentration of the vitamin. Vitamin E 
in a dose of 200 IU twice daily acts an antioxidant and improves sperms’ ability to 
impregnate. 
 
Selenium: 
  Men with reduced sperm motility, supplementation with selenium (100 mcg 
per day for three months) significantly increased sperm motility, but it had no effect on 
sperm count. Selenium is one of the important ingredients that is very often lacking in 
order mean and can be found in horsetail, which has been used with success in ED 
following  prostatic enlargement. 
 
 
L- Carnitine: 
 Sperm motility also increased both in quantitative and qualitative manners. In a 
multicentric study, increase in the sperm motility was also observed in terms of both 
rapid linear progression and linearity index along with that the sperm output after oral 
administration of L -carnitine in patients with idiopathic asthenozoospermias.  Two 
amino acids Iysine and methionine that is necessary for the biosynthesis of L-carnitine in 
the body. 
 
Antioxidants : 
 Polyunsaturated fatty acids and phospholipids are key constituents in the sperm 
cell membrane and are highly susceptible to oxidative damage. Sperm produce controlled 
concentrations of reactive oxygen species, such as the superoxide anion, hydrogen 
peroxide, and nitric oxide, which are needed for fertilization; however, high 
concentrations of these free radicals can directly damage sperm cells. Disruption of this 
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delicate balance has been proposed as one of the possible etiologies of idiopathic male 
infertility. About some Anti-oxidants, 
 
 Vitamin A alone improved sperm function and IVF rates in studies.  
 Vitamin A, Vitamin E, and essential fatty acids (omega-3 fats) were shown 
to increase sperm count in another study.  
 Folic acid and zinc may increase sperm concentration.  
 The bottom line: having a healthy diet is important for male fertility. If you 
are having trouble conceiving, re-evaluate your diet. You should have a diet 
rich in a variety fruits and vegetables and take a good quality multivitamin 
daily. You may also consider taking an omega-3 supplement, if your intake 
of fish is low.  
 
 
Coenzyme Q-10 : 
 In sperm cells, coenzyme Q10 (CoQ10) is concentrated in the mitochondrial mid-
piece, where it is involved in energy production. It also functions as an antioxidant, 
preventing lipid peroxidation of sperm membranes. When sperm samples from 22 
asthenospermic men were incubated in vitro with 50 microM CoQ10, significant 
increases in motility were observed. CoQ10 (60 mg) was given to 17 infertile patients for 
a mean 103 days, and although there were no significant changes in standard sperm 
parameters, there was a significant improvement in fertilization rate (p<.0.05).52 In 
another study, 10 mg/day of coenzyme Q7 (an analog of CoQ10) was given to infertile 
men, with resulting increases in sperm count and motility. 
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Normal Values - WHO Criteria: 
  The WHO reference values for a normal semen analysis are defined as 
given below: 
 Volume – 2 ml or more 
 Total sperm count - 40 millions per ejaculate or more 
 Sperm concentration - 20 millions per ejaculate or more 
 PH – 7.2 or higher 
 Motility - 50 % or more motile 
 25% or more with progressive motility, within 60 minutes of ejaculation 
Motility is graded from a to d according to WHO manual criteria, 
 a – Fast progressive. 
Sperms are those which swim forward fast in a straight line, like guided 
missiles 
 b – Slow progressive. 
Sperms swim forward, but either in a curved or crooked line or slowly. 
 c – Non progressive. 
Sperms move their tails, but do not move forward. ( local motility only ) 
 d – Immotile. 
Sperms do not move at all. 
 Sperms of grade c & d are considered poor. 
 
 
Morphology: 
 
 Head - The head should be oval and smooth. 
 Mid piece - the mid piece should be straight and slightly thicker than the tail. 
 Tail - the tail should be single, unbroken, straight and without coil. 
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LITERATURE REVIEW OF TRIAL DRUGS 
 þºôÒ§¸¡ø : 
  
Botanical Name  :Plantago  ovata 
Family             : Plantaginaceae  
À.¯   :Å¢¨¾ 
¦ºö¨¸: 
• ¯ÃÁ¡ì¸¢  (Tonic) 
• º¢Ú¿£÷ ¦ÀÕì¸¢ (Diuretic) 
• ¯ûÇÆÄ¡üÈ¢ (Demulcent) 
• ÅÈðº¢Â¸üÈ ¢ (Emollient) 
 
Ì½õ   (properties)  : 
  
 Commonly used as good LAXATIVE. 
 One very good & easy way to retain fertility in men is to use ISABGOL . 
 
º¡¾¢ì¸¡ö :- 
 
Botanical Name  :  Myristica fragrans 
Family         :  Myristicaceae 
 
À.¯   :¸¡ö 
Í¨Å  :ÐÅ÷ôÒ,¸¡÷ôÒ 
¾ý¨Á :¦ÅôÀõ 
À¢¡¢×  :¸¡÷ôÒ 
 
 
 
¦ºö¨¸: 
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• ¦ÅôÀÓñ¼¡ì¸¢ (Stimulant) 
• ÁñãðÊ  (Aromatic) 
• ¸¡Áõ¦ÀÕì¸¢ (Aphrodisiac) 
• ¯ÃÁ¡ì¸¢  (Tonic) 
• «¸ðÎÅ¡öÅ¸üÈ¢(Carminative) 
• ã÷î¨ºÔñ¼¡ì¸¢(Narcotic) 
  
¾¡Ð ¿ð¼õ §À¾¢ ºÕÅ¡º¢Âõ º¢Ã §¿¡ö 
µÐ ÍÅ¡ºõ¸¡ºõ ¯ð¸¢Ã¡½¢-§Å§¾¡ 
ÊÄì¸¡ö ÅÕõÀ¢½¢§À¡õ ²üÈÁÂø À¢ò¾õ 
ÌÄì¸¡ö ÂÕóÐÅ÷ìÌ ÜÚ. 
 
    - «¸ò¾¢Â÷ Ì½Å¡¸¼õ 
    (Ì½À¡¼õ Àì¸õ ±ñ:430) 
Ì½õ   (properties)  : 
 
 It acts as an aphrodisiac by stimulating the central nervous system. 
 It has a tranquilizing effect that helps to avert premature ejaculation. 
 
 
¿£÷ÓûÇ¢ Å¢¨¾ :- 
 
Botanical Name        :Hygrophila spinosa 
Family            :  Hygrophilaceae 
À.¯   :¦ºÊ,â,Å¢¨¾ 
Í¨Å  :þÉ¢ôÒ,º¢Ú ¨¸ôÒ 
¾ý¨Á :¾ðÀõ 
À¢¡¢×  :þÉ¢ôÒ 
 
 
 
¦ºö¨¸: 
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• º¢Ú¿£÷ ¦ÀÕì¸¢ (Diuretic) 
• ¸¡Áõ¦ÀÕì¸¢ (Aphrodisiac) 
 
Å¢óÐ×Á¡õ ¾¡Ð×Á¡õ §Á¸§Ã¡¸õ ¦¾¡¨ÄÔõ 
¯óÐ Á¾¢º¡Ãõ ´Æ¢Ôõ¸¡ñ-ÅóÐ¼Ä¢ø 
²È¢ÂÉ£÷ Å£ì¸õ ±ÈíÌõ þ¨ÇôÒÁÚõ 
ÜÈ¢Â ¿£÷ÓûÇ¢ Å¢¨¾ìÌ. 
 
     - «¸ò¾¢Â÷ Ì½Å¡¸¼õ 
     (Ì½À¡¼õ Àì¸õ ±ñ:587) 
 
Ì½õ   (properties)  : 
 
 It has aphrodisiac and spermatogenic effect against infertility may be due 
to hormonal and neurohumoral changes, which play an important role in 
the sexual behaviour and fertility disorders. 
 
¸ü¸ñÎ :  
 
Botanical Name        :Sacchrum officinarum 
Family            : Poaceae 
 
Í¨Å  :þÉ¢ôÒ 
¾ý¨Á :¾ðÀõ 
À¢¡¢×  :þÉ¢ôÒ 
 
®È¢ý ¾ÊôÒ Á¢ÕÁÖõÀø Å¡ó¾¢¸Ùõ 
º£Ú¸À ÓðÊÉÓõ §ºÃ¡§¾ - §¾È¢Â 
¦º¡ü¸ñ ÊÇõÌÂ¢ø¸û ÝÆ Á¼Å§É! 
¸ü¸ñ ¦¼½×¨ÃìÌõ ¸¡ø. 
 
    - «¸ò¾¢Â÷ Ì½Å¡¸¼õ 
    (Ì½À¡¼õ Àì¸õ ±ñ:238) 
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DRUGS OF ISABGOL CHOORANAM : 
                                                             
                   
 
                                                                                                      
 
 
 
 
  
                       
                               
                                  
  
ISABGOL VITHAI NEERMULLI VITHAI 
SATHIKKAI PANAM KARKANDU 
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MATERIALS & METHODS 
PROTOCOL 
Introduction: 
 
  The clinical trial for male infertility was decided to be conducted as an 
open label study. 
 
Data Collection: 
Literary evidence from various, 
  • Siddha books 
  • Medical journals 
  • Internet 
 
Trial Spot: 
 
  The entire study was conducted on patients attending the OPD of 
Government Siddha Medical College,  Aringnar Anna Hospital of Indian Medicine 
campus,  Arumbakkam, Chennai-106, during the period 2011-2012. 
 
Population: 
 
  The population consists of male infertility patients [sperm concentration 
less than 45 millions/ml  (or) sperm motility below 50%] satisfying the inclusion and  
exclusion criteria mentioned below. 
 
Inclusion Criteria: 
 
   Age 21 – 45 years 
   Oligospermia (low number of sperm) 
   Asthenozoospermia  (poor sperm motility) 
   Teratozoospermia(sperm carry more morphological defects than usual) 
   Oligo astheno teratospermia 
   Willing to give semen for the investigation 
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Exclusion Criteria: 
   Azoospemia 
   Hydrocele & Varicocele 
   Diabetes mellitus 
   Hypertension 
   Cardiac diseases 
 
Duration of Treatment : 
  60 to 90 days.  
 
  Patients were followed under the guidance and supervision of the 
HOD,Professor, Reader, Lecturer and Asst. Lecturer of the Maruthuvam, 
P.G.Department, GSMC, Chennai-106. 
  20 patients were selected and carefully studied for their history, clinical 
examinations, investigations and management. 
 
Evaluation of Clinical Parameters: 
 
  The history includes past, personal, family, occupation, dietary habits, 
seasonal history, and associated history. 
 
Clinical Investigations : 
Blood :- 
 TC (cells /cu mm) 
 DC (%),  
 ESR (mm) 
 Hb (gms%) 
 Sugar 
 VDRL 
 Urea 
 S.Creatinine 
 S.Cholesterol 
Urine:- 
 Albumin 
 Sugar 
 Deposits 
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Semen Analysis: 
 Volume 
 Colour 
 Appearance 
 Viscosity Liqufication time 
 Sperm Concentration (millions/ml) 
 Motility (%) 
 Morphology (%) 
Siddha Assessments : 
 Envagai thervugal 
 Neerkuri 
 Neikkuri 
  A case sheet format was prepared on the basis of the Siddha methodology 
example envagai thervvugal, mukkutram, nilam, kaalam, udal thathugal, including 
neerkuri and neikuri. Individual case sheet was maintained for each patient at 
outpatient department. 
 
TRIAL MEDICINES 
Drug Name  : Isabgol Chooranam 
Text reference: Koshayi Anuboga Vaidhya  Bramma Ragasiyam , page no :108. 
Ingredients: 
 Isabgol   - 1 part 
 Sadikkai  -2 part 
 Neermulli vithai  -2 part 
 Karkandu   -6 part 
 
Procedure: 
  All the drugs were dried well in shadow and made into fine powder. And  
they were put in a bottle and mixed thoroughly. 
 
Dosage: 
  1 gm, 2 times daily with cow’s milk after meals. 
 
Indications: 
 Aphrodisiac 
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ISABGOL CHOORANAM 
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Results & Observations 
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RESULTS AND OBSERVATIONS: 
 
The factors considered for the purpose of the study comprised of the following: 
 
 Age Distribution 
 Thinai 
 Paruva kaalam 
 Occupational status 
 Socio economic Status 
 Food habits 
 Personal habits 
 Symptoms 
 Classifications of results according to Vali, Azhal & Iyyam 
 Udal kattugal 
 Enn vagai thervu 
 Naadi 
 Classification on the basis of Neikkuri 
 Clinical progress 
 Results after treatment. 
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Age Distribution:- 
 
Sl.NO 
 
     Age        No.of patients/20 Percentage 
 
   1. 
 
21-30 
 
                       11 
  
         55% 
 
   2. 
 
31-40 
 
                         9 
 
         45% 
 
                   
 
Inference: 
 
 According to the above mentioned data 55% of patients were in age groups 
21-30 years, 45% of patients were in age group 31-40 years. 
 
 
 
55%
45%
0%
10%
20%
30%
40%
50%
60%
21-30 31-40
AGE DISTRIBUTION
PERCENTAGE
94 
 
 
Thinai: 
 
 
Sl.No 
 
Thinai 
 
No.of patients/20 
 
     Percentage 
  1 Kurinji              0             0% 
  2 Mullai              0             0% 
  3 Marutham              6           30% 
  4 Neithal            14           70% 
  5 Paalai              0             0% 
 
                  
 
 
Inference: 
 From the above data 70% of patient from neithal, 30% of cases from 
marutham 
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Paruva kaalam : 
 
                   
Inference : 50% of cases came in kaar kalam and 15% of cases  in muthuvenil 
kalam and 25% of cases in koothir kalam. 
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ELAVENIL 
MUDHUVENIL
Sl.No   Paruva Kaalam         Months No.of 
patients/20 
   
  Percentage 
  1 Kaar kalam  Avani, Puratasi, 
Mid Aug-Mid Oct 
            10       50% 
  2 Koothir kalam Iyppasi, Kaarthigai 
Mid Oct-Mid Dec 
              5       25% 
  3 Munpani kalam Margazhi, Thai 
Mid Dec-Mid Feb 
              0         0% 
  4 Pinpani kalam Maasi, Panguni 
Mid Feb-Mid April 
              0         0% 
  5 Elavenil kalam Chithirai, vaigasi 
Mid April- Mid June 
              2       10% 
  6 Mudhuvenilkaalam Aani, Aadi 
Mid June-Mid Aug 
              3       15% 
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Occupational Status: 
 
 
Sl.No 
 Occupational   
status 
 
No.of patients/20 
 
Percentage 
`  1 Drivers              5            25% 
   2 Labourers              9          45% 
   3 Professionals               3          15% 
   4 Businessman              3          15% 
 
               
 
Inference 
25% of cases were drivers. 
45% of cases were  labourers. 
15% of cases were Business Man. 
15% of cases were professionals. 
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Socio Economic Status:  
 
 
Sl.No 
Socio Economic 
Status 
 
No.of patients/20 
 
Percentage 
  1 Low income group 
(below 10000/month) 
            10       50% 
  2 Middle income group 
(below 15000/month) 
             5       25% 
  3 High income group 
(below 20000/month) 
             5       25% 
 
                
 
Inference 
 50% of cases belong to Low income group and 25% of patients belong to 
lower income group. 25% of cases belong to high income group. 
Food Habits: 
50%
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High income group 
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Sl.No 
 
Food Habit 
 
No.of patients/20 
 
Percentage 
  1. Vegetarian Diet             5       25% 
  2. Mixed Diet 
(incuding non-veg) 
          15       75% 
 
 
                    
 
Inference 
 
75% of cases were mixed diet (incuding non-vegetarian). 
25% of cases were vegetarian . 
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Personal Habits: 
 
 
Sl.No 
  
Personal Habits 
 
No.of patients/20 
 
Percentage 
  1 Smoker               5         25% 
  2 Alcoholic               5         25% 
  3 Tobacco chewing               0           0% 
  4 Others             10         50% 
     
                 
 
 
Inference 
  25% of cases were smokers ,  25% of cases were alcoholic & 50% were 
having other habits. 
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Symptoms: 
 
 
Sl.No 
 
Symptoms 
 
No.of patients/20 
 
Percentage 
  1 Premature ejaculation              12        60% 
  2 Erectile Dysfunction               6        30% 
  3 Nocturnal Emission               9        45% 
  4 No symptoms               5       25% 
  
 
                       
      
Inference 
 60% of cases came with complaints of premature ejaculation and 30% of 
cases with erectile dysfunction, 45% cases with nocturnal emission and 25% of cases 
had no symptoms. 
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Vatham: 
 
 
Sl.No 
 
Vatham 
 
No.of patients/20 
 
Percentage 
  1 Pranan              0             0% 
  2 Abanan            20         100% 
  3 Vyanan              5           25% 
  4 Udhanan   0             0% 
  5 Samanan              0             0% 
  6 Nagan              0              0% 
  7 Koorman              7           35% 
  8 Kirukaran              0             0% 
  9 Devathathan              0             0% 
 10 Dhananjeyan              0             0% 
 
                  
Inference 
 Abaanan was affected in 100% of patients,Koorman was affected in 35% of 
patients  and Vyanan was affected in 25% of patients. 
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Pitham: 
 
 
Sl.No 
  
Pitham 
 
No.of patients/20 
 
Percentage 
  1 Anar Pitham             0         0% 
  2 Ranjaga Pitham             0         0% 
  3 Sadhaga Pitham             0         0% 
  4 Aalosaga Pitham             7        35% 
  5 Prasaga Pitham             3        15% 
 
                  
 
Inference 
 Saathagam was affected in 35% of patients. Prasaga pitham was affected in 
15% of patients 
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IYYAM: 
 
 
 
 
 
 
 
 
 
 
 
 
          
 
Inference 
 Tharpagam was affected in 35% of patients and Santhigam in 20% of 
patients. 
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Sl.No 
  
Iyyam  
 
No.of patients/20 
 
Percentage 
   1 Avalambagam              0           0% 
   2 Kilethagam              0           0% 
   3 Bothagam              0           0% 
   4 Tharpagam              7          35% 
   5 Sandhigam              4          20% 
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Udal Kattugal: 
 
 
Sl.No 
  
Udal Kattugal 
 
No.of patients/20 
 
Percentage 
     1 Saaram               20            100% 
     2 Senner                0              0% 
     3 Oon                0              0% 
     4 Kozhuppu                0              0% 
     5 Enbu                4            20% 
     6 Moolai                0              0% 
     7 Sukkilam               20            100% 
 
                   
 
Inference : 
 Both Saaram and Sukkilam were affected in 100% of patients and Enbu was 
affected in 20% of patients. 
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Enn Vagai Thervu: 
 
 
Sl.No 
Enn Vagai 
Thervu 
 
No.of patients/20 
 
Percentage 
   1 Naa             0            0% 
   2 Niram             0            0% 
   3 Mozhi             0            0% 
   4 Vizhi             7          35% 
   5 Naadi           20        100% 
   6 Sparism             0            0% 
   7 Malam             0            0% 
   8 Moothiram             0            0% 
 
                 
Inference 
 Naadi was affected in 100% of patients and 35% of patients vizhi  was 
affected. 
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Naadi: 
 
 
Sl.No 
 
          Naadi 
 
No.of patients/20 
 
Percentage 
   1 Vathapitham                8       40% 
   2 Pithavatham              12       60% 
 
                 
 
Inference 
  40% of patient’s vatha pitham naadi was felt and  60% of cases 
 Pitha vatha naadi was felt. 
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Neikkuri: 
 
 
Sl.No 
 
      Neikkuri 
 
No.of patients/20 
 
Percentage 
    1           Vali 
(spreads like snake) 
                
               7       
       
       35% 
    2          Azhal 
(spreads like ring) 
           
             13 
       
       65% 
    3          Iyyam 
(stands like pearl) 
                
               0 
        
        0% 
 
                
 
Inference: 
 65% of cases show azhal neikuri and 35% shows vali neikkuri. 
 
 
35%
65%
0%
NEIKKURI
VALI
AZHAL
IYYAM
108 
 
Clinical Progress: 
 
 
Sl.No 
 
Symptoms 
No.of patients/20 Percentage 
      BT    AT    BT  AT 
  1 Premature 
ejaculation 
      12     4   60%   20% 
  2 Erectile 
Dysfunction 
       6     2   30%   10% 
  3 Nocturnal Emission        9     2   45%  10% 
  4 No symptoms        5     5    25%  25% 
 
                 
Inference 
   Before treatment 60% of cases had premature ejaculation, 45% of 
cases had  nocturnal emission & 30% having erectile dysfunction. 
  After treatment  premature ejaculation ,nocturnal emission were 20% 
and 10% of cases respectively & 10% having erectile dysfunction. 
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Gradation of results: 
 
 
Sl.No 
 
Gradation of results 
 
No.of patients/20 
 
Percentage 
   1 Good Improvement              10        50% 
   2 Moderate Improvement                5        25% 
   3 Poor Improvement                5        25% 
 
                     
 
 
Inference 
  50% of Patients show good improvement, 25% of shows moderate 
improvement and 25% of cases shows poor improvement. 
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LABORATORY INVESTIGATION REPORT (OP) 
 
 
TC – Total Count        Hb – Haemoglobin       OEC – Occasional Epithelial Cells 
Dc – Differential Count               ESR – Erythrocyte Sedimentation Rate     OPC – Occasional Pus Cells 
P – Polymorph        Alb – Albumin       FPC – Few Pus Cells 
L – Lymphocyte        Sug – Sugar        FEC – Few Epithelial Cells 
  E – Eosinophil        Dep – Deposits 
 
SL. 
NO. 
OP. NO.              
 
NAME 
 
AGE 
 
HEAMOTOLOGICAL REPORT 
URINE ANALYSIS STOOL  EXAMINATION 
BEFORE TREATMENT AFTER TREATMENT ESR(mm) HB(Gm) 
TC 
(Cu/mm) 
DC 
TC 
(Cu/mm) 
DC BT AT 
BT AT 
BT AT BT AT 
P L E P L E ½ Hr 1 Hr ½ Hr 1 Hr Alb Sug Dep Alb Sug Dep Ova Cyst Ova Cyst 
1 626 Iyyanar 32 9600 45 32 3 9700 55 36 3 2 5 3 6 14 14.2 Nil Nil OPC Nil Nil Nil Nil Nil Nil Nil 
2 204 Dillibabu 26 9400 57 38 5 9600 60 37 4 3 5 3 8 12.8 13 Nil Nil OPC Nil Nil OPC Nil Nil Nil Nil 
3 6178 Thamaodharan 22 9400 58 34 6 9200 55 32 5 2 5 4 10 13 12.8 Nil Nil OPC Nil Nil OPC Nil Nil Nil Nil 
4 1117 Venkatesan 30 9400 58 39 3 9000 60 38 2 10 22 9 18 12.4 12.5 Nil Nil OPC Nil Nil Nil Nil Nil Nil Nil 
5 7356 Sudhagar 40 10600 62 34 4 10450 55 30 4 7 17 8 18 14 14.1 Nil Nil OPC Nil Nil Nil Nil Nil Nil Nil 
6 7507 Vijay 28 9400 56 39 5 9600 60 35 6 12 24 10 15 13 13 Nil Nil OPC Nil Nil Nil Nil Nil Nil Nil 
7 5744 Raj 39 9700 58 37 2 9700 55 35 3 10 18 15 20 12.5 12.1 Nil Nil FPC Nil Nil Nil Nil Nil Nil Nil 
8 1102 Mohan 34 10700 66 30 4 10800 65 30 5 2 3 4 6 14 14 Nil Nil OPC Nil Nil OPC Nil Nil Nil Nil 
9 6292 Saravanan 31 9300 57 38 5 9400 55 35 6 10 20 9 18 13.8 13.7 Nil Nil OPC Nil Nil OPC Nil Nil Nil Nil 
10 201 Azhagiri 36 9000 58 38 4 9200 56 35 4 2 4 3 6 14.8 15 Nil Nil OPC Nil Nil OPC Nil Nil Nil Nil 
11 4027 Shanmugavel 28 9000 60 32 8 8800 62 30 6 6 12 5 10 12.6 12.5 Nil Nil FPC Nil Nil FPC Nil Nil Nil Nil 
12 195 Aanandhan 24 9700 54 42 4 9600 58 40 5 10 22 8 18 14 13.5 Nil Nil FPC Nil Nil OPC Nil Nil Nil Nil 
13 1063 Dhilipkumar 25 10100 59 37 4 10300 60 36 3 15 25 10 13 13.2 13 Nil Nil OPC Nil Nil Nil Nil Nil Nil Nil 
14 5685 Dilli 40 10700 62 31 7 10500 60 34 8 15 30 12 18 15 14.5 Nil Nil OPC Nil Nil Nil Nil Nil Nil Nil 
15 1924 Sridhar 26 9800 55 42 3 9750 58 40 4 5 22 4 10 12.2 12.5 Nil Nil OPC Nil Nil OPC Nil Nil Nil Nil 
16 4261 Sundhar 34 9200 56 38 6 9350 55 42 5 5 10 8 16 12.4 12.5 Nil Nil OEC Nil Nil Nil Nil Nil Nil Nil 
17 5023 Babu  28 9400 58 39 3 9450 56 40 2 3 5 4 8 12 12 Nil Nil OEC Nil Nil Nil Nil Nil Nil Nil 
18 518 Subramani 27 9600 59 37 4 9550 60 35 3 7 12 10 14 13 12.5 Nil Nil OEC Nil Nil Nil Nil Nil Nil Nil 
19 7130 Vinayagamorthy 33 9600 58 36 6 9600 60 35 3 7 13 6 14 12.4 13 Nil Nil OPC Nil Nil Nil Nil Nil Nil Nil 
20 2709 Balamurgan 23 9000 59 35 6 9100 58 34 5 6 10 5 12 14.6 14.6 Nil Nil Nil Nil Nil Nil Nil Nil Nil Nil 
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   NO .OF OP PATIENTS-BEFORE TREATMENT AND AFTER TREATMENT 
 
S.No 
 
O.P. NO. 
 
NAME 
 
AGE 
 
SEMEN ANALYSIS 
 BEFORE TREATMENT 
 
SEMEN ANALYSIS AFTER 
TREATEMNT 
 
TOTAL NO. OF 
DAYS  
 
        RESULT 
1. 626 Iyyanar 32 TSC – 20 million/cu. mm 
SM -20 % 
TSC – 70 million/cu. Mm 
SM – 48% 
105 Days  Good 
Improvement 
2. 204 Dillibabu 26 TSC -25 million/cu. mm 
SM - 55 % 
TSC – 48 million/cu. Mm 
SM - 58 % 
65 Days Moderate 
Improvement 
3. 6178 Thamodharan 22 TSC –17 million/cu. mm 
SM - 07 % 
TSC – 25 million/cu. Mm 
SM - 10 % 
78 Days Poor 
Improvement 
4. 1117 Venkatesan 30 TSC – 19 million/cu. mm 
SM - 24 % 
TSC – 59 million/cu. Mm 
SM - 50% 
115 Days Good 
Improvement 
5. 7356 Sudhagar 40 TSC – 09 million/cu. mm 
SM - 03 % 
TSC –55 million/cu. Mm 
SM - 35 % 
75 Days Good 
Improvement 
6. 7507 Vijay 28 TSC – 67 million/cu. mm 
SM - 15 % 
TSC – 70 million/cu. Mm 
SM - 30 % 
90 Days Moderate 
Improvement 
7. 5744 Raj 39 TSC – 15 million/cu mm 
SM - 04 % 
TSC – 45 million/cu. Mm 
SM - 28 % 
95 Days Good 
Improvement 
8. 1102 Mohan 34 TSC – 35 million/cu. mm 
SM - 30 % 
TSC – 50 million/cu. Mm 
SM - 55 % 
110 Days Moderate 
Imporvement 
9. 6292 Saravanan 31 TSC – 60 million/cu. mm 
SM - 20 % 
TSC – 85 million/cu. Mm 
SM - 45 % 
85 Days Good 
Improvement 
10. 201 Azhagiri 36 TSC – 12 million/cu. mm 
SM - 03 % 
TSC – 16 million/cu. Mm 
SM - 04 % 
65 Days Poor 
Improvement 
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11. 4027 Shanmugavel 28 TSC – 02 million/cu. mm 
SM - 3 % 
TSC –45 million/cu. mm 
SM - 45 % 
62 Days Good 
Improvement 
12. 195 Aanandhan 24 TSC – 50 million/cu. mm 
SM - 20 % 
TSC –68 million/cu. mm 
SM - 30 % 
87 Days Moderate 
Improvement  
13. 1063 Dhilipkumar 25 TSC –45 million/cu. mm 
SM - 30 % 
TSC – 70 million/cu. mm 
SM - 53 % 
76 Days Good 
Improvement 
14. 5685 Dilli 40 TSC – 15 million/cu. mm 
SM – only few seen 
TSC – 45 million/cu. mm 
SM – only few seen 
92 Days Moderate 
Improvement 
15. 1924 Sridhar 26 TSC –59 million/cu. mm 
SM - 12 % 
TSC –75 million/cu. mm 
SM - 40 % 
75 Days Good 
Improvement 
16. 4261 Sundar 34 TSC – 25 million/cu. mm 
SM - 10 % 
TSC – 50 million/cu. mm 
SM - 50 % 
58 Days Good 
Improvement 
17. 5023 Babu 28 TSC – 09 million/cu. mm 
SM - 2 % 
TSC – 56 million/cu. mm 
SM - 55 % 
95 Days Good 
Improvement 
18. 518 Subramani 27 TSC – 20 million/cu. mm 
SM - 28 % 
TSC – 30 million/cu. mm 
SM - 25 % 
49 Days Poor 
Improvement 
19. 7130 Vinayaga 
moorthy 
33 TSC – 18 million/cu. mm 
SM - 20 % 
TSC – 20 million/cu. mm 
SM - 15 % 
56 Days Poor 
Improvement 
20. 2709 Balamurugan 23 TSC – 70 million/cu. mm 
SM - 13 % 
TSC – 75 million/cu. mm 
SM - 35 % 
45 Days Moderate 
Improvement 
 
 
 
BEFORE TREATMENT                                                                                                      Mr.Sudhakar 40/M 
 
AFTER TREATMENT  Mr.Sudhakar 40/M 
 
   BEFORE TREATMENT             Mr. Ayyanar 33/M 
 
   AFTER  TREATMENT             Mr. Ayyanar 33/M 
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DISCUSSION : 
 
  One of the Predominant disorders that endanger human species is 
INFERTILITY in Both men and women. The incidence of infertility is comparatively 
higher in males became of the drastic changes in human life style – irregular food habits, 
high calorie food items, fast food behavioral changes. Environmental toxins and changed 
compounds used for dispensing various ailments. 
  It has been suggested that the average sperm count has been decreasing 
over the past 50 years. 
  Aan maladu as stated in yugi vaidya chindhamani has close resemblance 
with male infertility in Allopathic Medicine. 
  In my study 20 patients were treated in outpatient department of  Post 
graduate pothumaruthuvam department, Govt Siddha Medical College Hospital,  
Chennai – 106. 
  All patients were subjected to preliminary investigations which include 
haematological, urine examination, Semen Analysis before and after Treatment. 
  Before Treatment purgative was given to all patients to balance the altered 
three dhosas (vatha,pitha,kapha). 
  The Trial Medicine Isabgol chooranam  was administered from the next 
day onwards, course of the Treatment is  90 days. 
 
Age Distribution: 
  According to this study age distribution was 55% of patients were in 21- 
30years. 45% years patients were in 31-40 years.  
 
Distribution of Thinai: 
  According to this study 70% of the Patients came from Neithal because 
Chennai and surrounding areas come under Neithal thinai. 
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Paruvakalam: 
  According to this study 50% were in Kaar kaalam, 25% were in Koothir 
kaalam, 10% were in Elavenil kaalam, 15%  in Muthuvenil kaalam. Seasonal incidence is 
not affected their disease, male infertility. 
 
Occupational Status: 
  25% of the patients were Drivers, 45% of patients were working as a  
labourers, 15% of patients are Businessman, 15% of patients are Professionals. 
 
Socio Economic Status: 
  The majority of the Patients affected are from poor socio economic status. 
Poor hygienic conditions expose to polluted atmosphere and lower immune response 
made them prone to the disease. 
 
Food Habits: 
  25%  Patients were pure vegetarian, 75% were Mixed Diet (incuding non- 
vegetarian). Though a non-vegetarian diet account is not a reason for the occurrence of 
male infertility. 
 
Personal Habits: 
  In my study 25% of the Patients were using alcohol, 25% were smoker,  
50%  were having others. 
   The observation coincide with the conception that male infertility the 
disease may be due to smoking,  Alcohol consumption. 
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Symptoms: 
  According to this study 60% of the patients have premature ejaculation and 
30% of the patients had erectile dysfunction,45% patients have  nocturnal emission and 
25% have no symptoms. 
 
Classification of Results According To Vali, Azhal, Iyyam :- 
 
Vali : 
    a. Spermatogenesis, Premature Ejaculation, Nocturnal Emission are due to 
deranged Abana Vayu. 
    b.  Erectile dysfunction is due to deranged viyanan. 
    c.  In 100% patients  abanan was affected, viyanan was affected 25% of patients. 
And koorman affected in 35% of cases. 
 
Azhal: 
  Aalosaga Pitham  was affected in 75% of Patients. 
Iyyam: 
  Tharpagam may be affected in Patients hot atmosphere. 35% of patients 
Tharpagam were affected. 20 % of Patients santhigam was affected & produce Joint Pain. 
 
Udhal Kattugal: 
  Both bodily and mental weakness arises when saaram was affected. In 
100% of patients both the saaram and sukkilam were affected.In 20% of cases enbu was 
affected 
Envagai Thervu 
  Naadi was affected in 100% of patients and 35% of patients vizhi was 
affected. 
  
114 
 
 
Naadi 
  In 40% of patients Vatha Pitha Naadi was felt and 60% of patients Pitha 
Vadha Naadi was felt. 
Neikuri 
  65% of cases show azhal neikuri (spreads like ring) and 35% of cases show 
vali neikuri (spreads like snake). 
 
Clinical Progress: 
  Before treatment 60% of cases had premature ejaculation, 30% of cases had 
erectile dysfunction and 45% of cases had nocturnal emission. After treatment   
premature ejaculation, erectile dysfunction and nocturnal emission was relieved in 40% 
,20% and 35% of cases respectively. 
 
Trial Medicine: 
  All the 20 patients treated with the Trial Medicine   ISABGOL 
CHOORANAM with milk,twice a day for 90 days. The disease and treatment are based 
primarily on the derangement of Mukkutram, which again is based on the  Pancha 
bootham theory. Incidence of Aan maladu and treatment are also based on these primary 
principles of Siddha medicine. 
  The bootham raises azhal kuttram in the body and so as lead to general 
weakness and reduced sperm cell production. Increased azhal kuttram is brought to 
normal mainly  by enippu suvai and thuvarpu suvai.  
  These sweet and astringent tastes have the cool potency by nature. 
 A. Earth + Water = Sweet 
 B. Earth + Air = Astringent. Thus they decrease the azhal kuttram. Sweet taste 
increases the spermatogenesis. So I conclude the trial drugs cures the Aan Maladu and it 
comes under the Ethirurai Maruthuvam. 
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Pharmacological Report & Toxicological Evaluation: 
  The drug also subjected to pharmacological and toxicological tests in rat 
models. The results revealed that the drug had very effective results. There were no signs 
of toxicity as could be judged by the absence of undesirable clinical manifestations. 
Bio Statistical study: 
  The bio-statistical report of the clinical trial shows significant result. 
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Summary 
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SUMMARY 
 
  The aim of the study is to increase the sperm count and sperm motility in 
male infertility patient. The trial medicine Isabgol Chooranam was prepared as per 
literature. The duration of the trial period is 90 days. The trial dose is Isabgol Chooranam 
1gm ,twice a day with cow’s milk. I had selected 20 patients for the trial based on 
Inclusion and Exclusion criteria. Before treatment routine blood, urine and semen 
analysis taken in all 20 patients. Siddha methods like udal thathukkal, Envagai thervu, 
Neerkuri and Neikuri were noted in case sheet proforma. Patients were instructed to come 
for next review once in 7 days. 15 patients were come with clinical symptoms like 
premature ejaculation, erectile dysfunction, nocturnal emission . The entire details of the 
patients were noted in the case sheet proforma. 
 
Age : 
  Most of the patients were in the age group between 21-30 years. 
 
Thinai : 
  Most of the patients were from Neithal Thinai 70%. 
Kalam : 
  Seasonal Variances do not have any impact for affecting the people. 
 
Occupation: 
  The disease is more common in people working in hot atmosphere like 
Labourers. 
Diet & Personal habits: 
 
  People with habit of taking Vegetarian and Mixed Diet, smoking, Alcoholic 
 have more incidence of the disease. 
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Mukkutrum: 
  In Vali ,abaanan ,koorman and viyanan, in Azhal Aalosagam and in Iyyam 
tharpagam were affected in most of the cases. 
 
Udal Thathugal: 
  Saaram and sukkilam were affected in all the patients. 
 
Naadi : 
  Pitha vatha  naadi was most common naadi felt. 
 
Results after treatment: 
 
  50% of patients show good improvement, 25% of patients shows moderate 
improvement and in 25% of patients poor improvement was observed. 
. 
  The pharmacological studies reveal that trial drugs had good 
spermatogenesis effect in rats. The toxicity study revealed that there were no signs of 
toxicity as could be judged by the absence of undesirable clinical manifestations and no 
alteration in bio chemical markers. 
 
  The bio-statistical report of the clinical trial shows significant result. 
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CONCLUSION : 
 
 
 AAN MALADU (Male infertility) is primarly due to the derangement  of  
pitham. 
 The trial medicine Isabgol  chooranam predominating with Inippu and 
Thuvarppu taste respectively neutralizes the pitham. 
 From the pre clinical pharmacological studies it is evident that the medicine 
was significant Spermatogenesis  activity. 
 The Isabgol  chooranam do not produce any toxicity in preclinical study. So 
it is non toxic and safe drug for Aan maladu. 
 From the preclinical study  Isabgol chooranam increase the Testosterone 
level. 
 No contra indication was reported during the course of the treatment. 
 The trial medicine gave maximam relief from the symptoms of Aan maladu. 
 The prepration of trial medicine is so easy and economical. 
 Therefore the author concluded that the trial medicine ISABGOL 
CHOORANAM should be a very positive remedy for Aan maladu ( Male 
Infertility). 
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Bio-Chemical 
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BIO-CHEMICAL ANALYSIS OF TRIAL MEDICINES 
 
Preparation of Sodium Carbonate extract: 2 gm of the sample drug  is mixed  5 gm 
of Sodium carbonate and taken in a 100 ml beaker and 20 ml of distilled water is added.  
The solution is boiled for 10 minutes, cooled and then filtered.  The filtrate is called 
sodium carbonate extract. 
 
S.No. 
 
Experiment 
 
Observation  
 
Inference 
1 Test for Acid Radicals   
a. Test for Sulphate 
2 ml of the above prepared extract 
is taken in a test tube.  To this add 
2ml of 4% Ammonium oxalate 
solution. 
Absence of              
White  Precipitate 
 
Absent 
b. 2ml of extract is added with 2ml 
of dilute hydrochloric acid until 
the effervescence ceases off.  Then 
2ml barium chloride solution is 
added. 
Absence of              
White  Precipitate 
 
Absent 
2. Test for Chloride: 
2ml of extract is added with dilute 
nitric acid till the effervescence 
ceases.  Then 2ml of silver nitrate 
solution is added. 
 
white precipitate 
obtained 
 
Present 
  
125 
 
3. Test for Phosphate 
2ml of the extract is treated 
with 2 ml of Ammonium 
molybdate  solution and 2ml of 
concentrated nitric acid. 
Absence of 
Yellow Precipitate 
 
Absent 
4. Test for Carbonate: 
2ml of the extract is treated 
with 2ml of magnesium 
sulphate solution. 
Absence of white 
precipitate 
 
Absent 
5. Test for Sulphide: 
1 gm of the substance is treated 
with 2ml of concentrated 
Hydrochloric acid 
Absence of Rotten 
egg smelling 
 
             Absent 
6. Test for Nitrate: 
1gm of the substance is heated 
with copper turnings and 
concentrated sulphuric acid 
and viewed the test tube 
vertically down. 
Absence of reddish 
brown gas. 
      
            Absent 
7. 
a. 
Test for Fluoride and oxalate 
2ml of the extract is added with 
2ml of dilute acetic acid and 
2ml of calcium chloride 
solution and heated.  
Absence of white 
precipitate 
       
            Absent 
b. 5 drops of clear solution is 
added with 2ml of dilute 
sulphuric acid and slightly 
warmed to this, 1 ml of dilute 
potassium permanganate 
solution is added.  
Absence of KMNO4 
solution 
discolourisation.  
Absent 
8. Test for Nitrite 
3 drops of the extract is placed 
on a filter paper.  On that, 2 
drops a Acetic Acid and 2 
drops of Benzidine solution is 
placed. 
Absence of 
yellowish red colour 
 
           Absent 
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9. Test for Borate 
2 pinches of the substance is 
made into paste by using 
Sulphuric acid and Alcohol 
(95%) and introduced into the 
blue flame. 
Absence of Green 
tinged flame 
 
            Absent  
II. TEST FOR BASIC RADICALS  
10. Test for lead 
2 ml of the extract is added 
with 2 ml of Potassium iodide 
solution 
Absence of Yellow 
precipitate 
 
             Absent 
11a Test for Copper 
One pinch of substance is 
made into paste with 
concentrated Hydrochloric acid 
in a watch glass and introduced 
into the non luminous part of 
the flame. 
Absence of Bluish 
green coloured 
flame. 
 
             Absent 
b. 2ml of the extract is added with 
excess of Ammonia solution 
Absence of deep 
blue 
Absent 
12. Test for Aluminium 
To the 2 ml of extract.  Sodium 
Hydroxide solution is added in 
drops to excess. 
Absence of   White 
precipitate. 
Absent  
13a Test for Iron 
To the 2 ml of extract, 2 ml of 
Ammonium Thiocyanate 
solution is added. 
Absence of Blood 
red colour 
Absent  
b. To the 2 ml of extract, 2 ml of 
Ammonium Thiocyanate 
solution and 2 ml of 
concentrated Nitric Acid is 
added. 
Absence of Blood 
red colour. 
Absent 
14. Test for Zinc 
To the 2 ml of extract Sodium 
Hydroxide solution is added in 
Absence of  White 
precipitate . 
Absent 
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drops to excess. 
 15. Test for Calcium 
2 ml of the extract is added 
with 2 ml of 4% Ammonium 
Oxalate solution. 
White precipitate 
Obtained 
Present 
16. Test for Magnesium 
 2ml of extract, Sodium 
Hydroxide solution is added in 
drops to excess. 
Absence of   White 
precipitate. 
Absent 
17. Test for Ammonium 
 2 ml of extract few ml of 
Nessler’s Reagent and excess 
of Sodium Hydroxide solution 
are added. 
 
Absence of   
Reddish brown 
precipitate . 
 
Absent 
18. Test for Potassium 
A pinch of substance is treated 
with 2 ml of Sodium Nitrite 
solution and then treated with 2 
ml of Cobal Nitrate in 30% 
glacial Acetic acid. 
Yellow precipitate 
Obtained. 
Present 
19. Test for Sodium 
2 pinches of the substance is 
made into paste by using 
Hydrochloric acid and 
introduced into the blue flame. 
Absence of Yellow 
colour flame 
Absent  
20. Test for Mercury 
2 ml of the extract is treated 
with 2 ml of Sodium 
Hydroxide solution. 
Absence of yellow 
precipitate 
Absent  
21. Test for Arsenic 
2 ml of extract is treated with 2 
ml of silver Nitrate solution 
Absence of                                                                                                                    
Yellow precipitate. 
Absent  
22. Test for Starch 
2ml of extract is treated with 
weak iodine solution 
Bluecolour is 
obtained . 
Present 
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23. Test of reducing Sugar 
5ml of Benedicts qualitative 
solution is taken in a test tube 
and allowed to boil for 2 
minutes and added  10 drops of 
the extract and again boiled for 
2 minutes.  The colour changes 
are noted. 
Green colour is 
obtained. 
Present 
24.  Test of  the alkaliods               
2ml of the extract is treated 
with  2ml of potassium lodide 
solution. 
Red colour 
developed 
Present               
25. 
 
 
 
 
Test of  the proteins 
2ml of the extract is treated 
with  2ml of 5% NaOH ,mix 
well and add 2 drops of copper 
sulphate solution. 
Violet  colour 
developed 
Present   
 
RESULTS:  
The given sample contains. 
Drug  Name (Isabgol chooranam) –  
a. Chloride 
b. Calcium 
c. Pottassium 
d. Starch 
e. Reducing sugar 
f. Alkaloids 
g. Proteins. 
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ACUTE AND SUB ACUTE TOXICITY STUDY ON ISABGOL CHOORANAM 
Animals  
 Mice of either sex weighing 25-30g and rats weighing 210-240g were obtained from the 
animal house of Vels University. The animals were used with the approval of the Institute animal 
ethics committee and obtained from Vels University, Chennai. They were fed with a balanced 
standard pellet diet and maintained under standard laboratory conditions, providing 24-280C 
temperature, standard light cycle (12 h light, 12 h dark) and water ad libitum. Animals were kept 
in cages with raised floors of wide mesh to prevent coprophagy. Animal welfare guidelines were 
observed during the maintenance period and experimentation. The rats were randomly assigned 
to control and different treatment groups, six animals per group. The animals were acclimatized 
for one week under laboratory conditions.  
ACUTE TOXICITY STUDY-OECD 425 GUIDELINES  
 Acute oral toxicity test for the Isabgol Chooranam was carried out as per OECD 
Guidelines 425. As with other sequential test designs, care was taken to ensure that animals are 
available in the appropriate size and age range for the entire study. The test substance is 
administered in a single dose by gavage using a stomach tube or a suitable intubation cannula. 
The fasted body weight of each animal is determined and the dose is calculated according to the 
body weight. After the substance has been administered, food was withheld for a further 2 hours 
in mice. The animals were observed continuously for the first 4 h and then each hour for the next 
24 h and at 6 hourly intervals for the following 48 h after administering of the test drug, to 
observe any death or changes in general behaviour and other physiological activities. Single 
animals are dosed in sequence usually at 48 h intervals. However, the time interval between 
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dosing is determined by the onset, duration, and severity of toxic signs. Treatment of an animal 
at the next dose was delayed until one is confident of survival of the previously dosed animal.  
Observation of toxicity signs: General behavior, respiratory pattern, cardiovascular signs, motor 
activities, reflexes, change in skin and fur, mortality and the body weight changes were 
monitored daily. The time of onset, intensity, and duration of these signs, if any, was recorded.  
SUB-ACUTE TOXICITY  
 In a 28-days sub acute toxicity study, twenty four either sex rats were divided into four 
groups of 6 rats each. Group I that served as normal control was administered with distilled 
water (p.o.) while groups II, III and IV were administered daily with the Isabgol Chooranam 
(p.o.) for 28 days at a dose of 50, 100 and 200mg/kg respectively. The animals were then 
observed daily for gross behavioural changes and any other signs of subacute toxicity. The 
weight of each rat was recorded on day 0 and weekly throughout the course of the study, food 
and water consumption per rat was calculated. At the end of the 28 days they were fasted 
overnight, each animal was anaesthetized with diethylether, following which they were then 
dissected and blood samples were obtained by cardiac puncture into heparinised tubes. The blood 
sample collected from each rat was centrifuged with 3000 X g at 4oC for 10 min to separate the 
serum and used for the biochemical assays.  
Hematological and blood biochemical analyses:  
At the end of the study, all animals were kept fasted for 16-18 h and then anesthetized with 
anesthetic ether on the 28th day. Blood samples for hematological and blood chemical analyses 
were taken from retro orbital vein. Heparinized blood samples were taken for determining 
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complete blood count (white blood cell count, differential white blood cell count, platelet count, 
red blood cell count, hematocrit, and hemoglobin) by semiautomated hematology analyzer. The 
serum from non-heparinized blood was carefully collected for blood chemistry and enzyme 
analysis glucose, creatinine, total protein, albumin, total and direct bilirubins, serum glutamate-
oxaloacetate transaminase (SGOT), serum glutamate pyruvate transaminase (SGPT), and 
alkaline phosphatase (ALP)) were automatically determined using autoanalyzer. 
Necropsy:  
All rats were sacrificed after the blood collection. The positions, shapes, sizes and colors of 
internal organs were evaluated. The Spleen, Testes, Pancrea, Lung, Liver, Brain, Heart, Stomach, 
Intestine, Bone, Ovary, and Kidney tissues were excised from all rats to visually detect gross 
lesions, and weighed to determine relative organs’ weights and preserved in 10% neutral 
formalin for histopathological assessment. The tissues were embedded in paraffin, and then 
sectioned, stained with haematoxylin and eosin and were examined microscopically. 
Statistical analysis 
Values were represented as mean ± SEM. Data were analysed using one-way analysis of 
variance (ANOVA) and group means were compared using the Tukey-Kramer Multiple 
Comparison Test using Instat-V3 software. P values < 0.05 were considered significant. 
RESULTS AND DISCUSSION 
1) All the animals from control and all the treated dose groups up to 200 mg/kg survived 
throughout the dosing period of 28 days. 
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2) No signs of major or significant intoxication were observed in animals from lower to higher 
dose groups during the dosing period of 28 days. 
3) Animals from all the treated dose groups exhibited comparable body weight gain with that of 
controls throughout the dosing period of 28 days. 
4) Food consumption of control and treated animals was found to be comparable throughout the 
dosing period of 28days. 
5) Ophthalmoscopic examination, conducted prior to and at the end of dosing period on animals 
from control and all the treated dose groups did not reveal any abnormality. 
6) Haematological analysis conducted at the end of the dosing period on day 28, revealed no 
significant abnormalities attributable to the treatment. 
7) Biochemical analysis conducted at the end of the dosing period on day 28, revealed no 
remarkable abnormalities attributable to the treatment. 
8) Functional observation tests conducted at termination revealed no abnormalities. 
9) Urine analysis, conducted at the end of the dosing period in week 4 and at the end of recovery 
period in week 6, revealed no abnormality attributable to the treatment. 
10) Organ weight data of animals sacrificed at the end of the dosing period was found to be 
comparable with that of respective controls. 
11) Gross pathological examination did not reveal any abnormality. 
12) Histopathological examination did not reveal any abnormality. 
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CONCLUSION 
 Based on these findings, no toxic effect was observed upto 200mg/kg of Isabgol 
Chooranam treated via oral route over a period of 28 days. So, it can be concluded that the 
Isabgol Chooranam can be prescribed for therapeutic use in human with the dosage 
recommendations of upto 200mg/kg. body weight p.o. 
 
REFERENCES 
1. Benjamin, M.N., 1978.Outline of Veterinary Clinical Pathology. University Press, IOWA, 
USA., pp:229-232. 
2. OECD (testing guideline, 407), 1995. Repeat dose 28 days oral toxicity study in rodents; In 
Guidance document for the development of OECD guideline for testing of chemicals 
Environmental monographs No 76; http//www.oecd.ord/document/30/0.2340,en??2649-
34377-19166381111, 00html. 
3. OECD Principles on Good Laboratory Practice, 2001. In: Handbook, Good Laboratory 
Practice (GLP), Quality Practices for Regulated non Clinical Research and Development 
TDR PRD/GLP/01.2. 
4. Organization for Economic Cooperation Development (OECD) Guideline, 425,2000. 
Guideline Document on Acute Oral Toxicity. Environmental Health and Safety Monograph 
Series on Testing and Assessment No. 24. 
5. Ringler, D.H. and L.Dabich, 1979. Haematology and Clinical Biochemistry. In: The 
Laboratory Rat. Baker, J., J.R. Lindsey and S.H.Weisbroth (Eds.), Academic Press London, 
1: 105-118. 
135 
 
 
Table 1: Dose finding experiment and its behavioral Signs of Toxicity 
No Dose mg/kg 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
1 500 + - - + - + - - - - - - - - - - - - - - 
2 1000 + - - + - + - - + - - - - - - - + - +  - 
3 2000 + - - + - + + - + - - - + - - - + + + - 
1. Alertness 2. Aggressiveness 3. Pile erection 4. Grooming  5. Gripping  6. Touch 
Response 7. Decreased Motor Activity 8. Tremors 9. Convulsions 10. Muscle Spasm 
11. Catatonia 12. Muscle relaxant 13. Hypnosis 14. Analgesia 15.Lacrimation 16. 
Exophthalmos 17. Diarrhoea 18. Writhing 19. Respiration 20. Mortality 
 
 
 
 
 
Table 2. Body wt (g) of albino rats exposed to Isabgol Chooranam for 28days. 
Dose 
(mg/kg/day) 
Days 
1 7 14 21 28 
Control 210.50±6.52 212.16±6.40 215.48±5.42 221.52±8.00 223.11±5.88 
50 215.71±6.43 218.20±5.18 220.51±5.70 226.64±7.02 226.50±6.00 
100 213.42±5.45 216.14±6.18 220.00±6.61 224.10±7.10 227.72±7.12 
200 212.10±6.25 217.28±5.42 219.23±6.49 222.22±6.43 225.25±7.23 
Values are mean of 6 animals ± S.E.M. (Dunnet's test). nsP>0.05.  
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Table 3. Food (g/day) intake of albino rats exposed to Isabgol Chooranam for 
28days. 
Dose 
(mg/kg/day) 
Days (gms/rats) 
1 7 14 21 28 
Control 47.06±2.55 48.48±2.51 46.24±2.50 45.82±2.54 47.20±3.42 
50 46.24±2.17 46.43±2.40 46.40±2.46 49.14±2.90 48.52±3.05 
100 44.34±2.28 45.00±2.92 44.25±2.45 45.18±3.21 46.04±3.00 
200 45.60±2.55 45.20±2.18 46.51±2.82 45.31±2.40 45.14±3.14 
Values are mean of 6 animals ± S.E.M. (Dunnet's test). nsP>0.05. 
 
 
 
Table 4. Water (ml/day) intake of rats exposed to Isabgol Chooranam for 28days. 
Dose 
(mg/kg/day) 
Days(ml/rat) 
1 7 14 21 28 
Control 52.00±2.85 52.20±3.32 54.20±3.12 52.20±3.14 51.22±3.22 
50 53.10±2.63 50.12±3.04 45.21±4.02 46.50±3.00 44.52±2.48 
100 49.17±2.18 42.25±3.72 45.48±3.34 42.10±2.92 41.12±3.28 
200 54.30±3.52 54.72±3.00 52.42±3.82 48.20±3.12 47.32±3.62 
Values are mean of 6 animals ± S.E.M. (Dunnet's test). nsP>0.05. 
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Table.5.Hematological parameters after 28days treatment with Isabgol 
Chooranam in rats. 
Parameter Control 50mg/kg 100mg/kg 200 mg/kg 
Red blood cell 
(mm3) 
7.02±0.71 7.92±0.62 7.18±0.75 8.00±0.60 
HB (%) 15.21±0.43 15.10±0.41 15.56±0.42 15.00±0.44 
Leukocyte 
(x106/mL) 
10.00±1.6 10.35±2.2 10.02±2.1 10.36±1.32 
Plateletsin 
lakhs/cu.mm 
1.25±0.49 1.62±0.54 1.72±0.62 1.25±0.56 
MCV (gl) 54.42±5.20 53.12±4.22 54.00±5.24 55.10±4.80 
Neutrophil 5.45±1.23 5.42±1.21 5.18±0.96 5.14±3.72 
Lymphocyte 92.13±2.82 91.70±3.18 93.20±3.22 92.30±3.12 
Monocyte 2.2±0.30 2.0±0.23 2.21±0.24 2.30±0.28 
Eosinophil 1.00±0.00  1.0±0.22  1.0±0.11 1.00±0.11 
Basophil 0 0 0 0 
ESR(mm) 1±00 1±00 1±00 1±00 
PCV 45.30±2.42 45.26±2.12 45.04±3.02 45.42±3.42 
Values are mean of 6 animals ± S.E.M. (Dunnet's test). nsP>0.05. 
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Table 6. Effect of treatment with Isabgol Chooranam biochemical parameters. 
Dose (mg/kg) Control 50 mg/kg 100 mg/kg 200 mg/kg 
Total Bilirubin (mg/dL) 0.210±0.05 0.210±0.06 0.212±0.05 0.214±0.04 
Bilirubin direct 
(mg/dL) 
0.1±0.04 0.1±0.05 0.1±0.04 0.1±0.05 
Bilirubin 
indirect(mg/dL) 
0.1±00 0.1±00 0.1±00 0.1±00 
ALP (U/L) 376.42±11.10 370.12±10.30 374.12±10.00 372.1±12.32 
SGOT (U/L) 164.20±6.20 162.16±6.82 158.80±5.40 159.21±6.78 
SGPT(U/L) 45.8±3.42 45.2±3.24 45.00±2.84 46.22±3.14 
Total Protein(g/dl) 10.00±1.00 9.88±0.90 9.54±0.87 9.28±0.96 
Albumin(g/dl) 3.70±0.28 3.92±0.44 3.40±0.30 3.42±0.32 
Globulin(g/dl) 6.00±0.15 5.85±0.16 5.58±0.20 5.80±0.26 
Values are mean of 6 animals ± S.E.M. (Dunnet's test). nsP>0.05 Vs. control  
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Table-7 RFT 
Dose (mg/kg) Control 50 mg/kg 100 mg/kg 200 mg/kg 
Urea(mg/dL) 56.20±1.37 55.74±3.65 55.42±2.45 54.82±2.30 
Creatinine (mg/dL) 0.77±0.05 0.76±0.05 0.77±0.06 0.78±0.05 
Uric acid (mg/dL) 1.5±0.14 1.6±0.15 1.6±0.14 1.6±0.18 
Na m.mol 140.50±5.52 140.42±4.00 140.21±5.22 141.18±5.02 
K m.mol 20.15±2.81 19.58±1.82 20.10±1.68 20.52±2.24 
Cl m.mol 101.05±4.42 101.00±4.18 99.48±4.42 100.00±5.10 
 
 
 
 
 
Table-8. Lipid Profile 
 
Dose (mg/kg) Control 50 mg/kg 100 mg/kg 200 mg/kg 
Total cholestrol(mg/dL) 41.60±2.52 41.28±2.40 40.11±3.12 42.00±3.02 
HDL(mg/dL) 13.40±1.54 13.22±1.47 13.40±1.80 13.40±2.13 
LDL(mg/dL) 42.56±2.48 44.52±3.16 45.43±3.02 44.22±3.28 
VLDL(mg/dl) 16.30±2.28 15.72±2.53 16.00±1.42 15.00±1.20 
Triglycerides (mg/dl) 86.42±3.02 85.62±2.42 85.20±3.32 86.42±2.42 
TC/HDL ratio (g/dl) 3.52±0.25 3.60±0.28 3.55±0.30 3.45±0.28 
Blood glucose(mg/dl) 127.30±6.00 126.02±5.20 126.10±5.00 124.88±4.56 
Values are mean of 6 animals ± S.E.M. (Dunnet's test). nsP>0.05.Vs. control  
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Table-9 Urine Analysis 
 
 
 
 
 
Parameters Control 50 mg/kg 100 mg/kg 200 mg/kg 
Colour Yellow Yellow Yellow Yellow 
Transparency Clear Slightly turbid Slightly 
cloudy 
Slightly turbid 
Specific gravity 1.010 1.010 1.010 1.010 
PH >7.2 >8.0 >8.0 >9.0 
Protein Nil 3+ 3+ 3+ 
Glucose Nil Nil Nil Nil 
Bilirubin -ve -ve -ve -ve 
Ketones -ve +ve +ve +ve 
Blood Absent Absent Absent Absent 
Urobilinogen Normal Abnormal Abnormal Abnormal 
Pus cells 0-cells/HPF 1-cell/HPF 2-cells/HPF 1-cell/HPF 
RBCs Nil Nil 0-1cells/HPF Nil 
Epithelial cells Nil 1-cell/HPF Nil 1-cell/HPF 
Crystals Nil Nil Nil Nil 
Casts Nil Nil Nil Nil 
Others Bacteria seen Bacteria seen Bacteria seen Bacteria seen 
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Table 10. Effect of oral administration of Isabgol Chooranam on organ weight 
Dose (mg/kg) Control 50 mg/kg 100 mg/kg 200 mg/kg 
Liver (g) 5.21±0.14 5.28±0.12 4.98±0.10 5.12±0.14 
Heart (g) 0.60±0.04 0.60±0.05 0.57±0.04 0.58±0.04 
Lung (g) 1.45±0.15 1.46±0.12 1.48±0.14 1.50±0.14 
Spleen (g) 0.65±0.05 0.65±0.04 0.64±0.04 0.65±0.05 
Ovary (g) 1.70±0.14 1.72±0.15 1.78±0.18 1.74±0.15 
Testes (g) 1.47±0.10 1.49±0.12 1.56±0.15 1.54±0.15 
Brain (g) 1.57±0.15 1.56±0.13 1.56±0.14 1.55±0.14 
Kidney (g) 0.72±0.04 0.71±0.04 0.70±0.04 0.71±0.05 
Stomach (g) 1.35±0.13 1.36±0.10 1.35±0.11 1.35±0.10 
Values are mean of 6 animals ± S.E.M. (Dunnet's test). nsP>0.05.Vs control 
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HISTOPATHOLOGY of toxicological study 
Drug name: isabgol chooranam 
 
                            50 mg  100 mg   200 mg 
 
BONE               
 
BRAIN                
 
HEART                         
 
INTESTINE            
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SPERMATOGENIC ACTIVITY OF ISABGOL CHOORANAM AGAINST 2,3,7,8- 
 TETRACHLORODIBENZO-P-DIOXIN INDUCED OLIGOSPERMIC RATS 
INTRODUCTION  
 Infertility is the failure of a couple to conceive a pregnancy after trying to do so for at 
least one full year. In primary infertility, pregnancy has never occurred. In secondary infertility, 
one or both members of the couple have previously conceived, but are unable to conceive again 
after a full year of trying. Approximately 20% of couples struggle with infertility at any given 
time. Infertility has increased as a problem over the last 30 years. Some studies blame this 
increase on social phenomena, including the tendency for marriage and starting a family to occur 
at a later age. For women, fertility decreases with increasing age: 
 Infertility in married women ages 16–20 = 4.5%.  
 Infertility in married women ages 35–40 = 31.8%.  
 Infertility in married women over the age of 40 = 70%.  
 Presently, individuals often have several sexual partners before they marry and try to 
have children. This increase in numbers of sexual partners has led to an increase in sexually 
transmitted diseases. Scarring from these infections, especially from infection of the female 
reproductive organs seems to be in part responsible for the rise in infertility. Furthermore, use of 
some forms of the contraceptive called the intrauterine device (IUD) has contributed to an 
increased rate of pelvic inflammatory disease, with subsequent scarring. A study in 2001 found 
that copper IUDs have probably been wrongfully blamed for tubal infertility, while infection 
from the sexually transmitted disease chlamydia was likely the cause. 
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Causes & symptoms 
 Unlike most medical problems, infertility is an issue requiring the careful evaluation of 
two separate individuals, as well as an evaluation of their interactions with each other. In about 
3–4% of couples, no cause for their infertility will be discovered. About 40% of the time, 
infertility is due to a problem with the male; about 40% of the time, infertility is due to the 
female; and about 20% of the time, there are fertility problems with both the male and the 
female. 
The main factors involved in causing infertility include: 
 male problems: 35%  
 ovulation problems: 20%  
 tubal problems: 20%  
 endometriosis: 10%  
 cervical factors: 5%  
Male factors 
 Male infertility can be caused by a number of different characteristics of the sperm. To 
check for these characteristics, a sample of semen is obtained and examined under the 
microscope (semen analysis). Four basic characteristics are usually evaluated: 
 Sperm count refers to the number of sperm present in a semen sample. The normal 
number of sperm present in just 1 ml of semen is over 20 million. A man with only 5–20 
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million sperm is considered subfertile and a man with fewer than 5 million sperm is 
considered infertile.  
 Sperm are also examined to see how well they swim (sperm motility) and to be sure that 
most have normal structure.  
 Not all sperm within a specimen of semen will be perfectly normal. Some may be 
immature, and some may have abnormalities of the head or tail. A normal semen sample 
will contain no more than 25% abnormal forms of sperm.  
 Volume of the semen sample is important. An abnormal amount of semen could affect 
the ability of the sperm to successfully fertilize an ovum.  
 Men can be born with testicles that have not descended properly from the abdominal 
cavity into the scrotal sac, or may be born with only one instead of the normal two testicles. 
Testicle size can be smaller than normal. The presence of abnormally large veins (varicocele) in 
the testicles can increase testicular temperature, which decreases sperm count. History of having 
been exposed to various toxins, drug use, excess alcohol use, use of anabolic steroids, certain 
medications, diabetes, thyroid problems, or other endocrine disturbances can have direct effects 
on the formation of sperm (spermatogenesis). Problems with the male anatomy can cause sperm 
to be ejaculated not out of the penis, but into the bladder; and scarring from past infections can 
interfere with ejaculation. 
Treatment 
 Conventional treatment for infertility usually involves invasive and, expensive 
procedures. There are many alternative treatments available that can increase the chance of 
conception. Some have been proven effective in clinical studies. General measures to increase 
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fertility include monitoring ovulation and timing intercourse (optimal chance for conception is 
within six days prior to and including the day of ovulation); and quitting smoking, excessive 
drinking, and drug use. To improve sperm quality, men can wear boxer shorts instead of briefs. 
Both men and women can increase fertility by eating a well-balanced diet. Good food choices 
include legumes (especially soy), dark-colored vegetables, fruits, seeds, nuts, and sufficient good 
quality protein including meat, fish, and eggs. Some people think that refined sugar, processed 
cheeses, foods made with white flour, and chemical preservatives should be avoided. Adequate 
sleep is also important. The present study was conducted to evaluate the possibility of using 
Isabgol Chooranam as a therapeutic agent to treat spermatogenic disorders in the animal models. 
MATERIALS AND METHODS 
Chemicals  
 The 2,3,7,8-Tetrachloro dibenzo-p-dioxin and necessary chemicals and reagents were 
obtained from Sigma chemicals. All other solvents and Analytical Kits were of analytical grade 
and obtained from qualigen fine chemicals and Artek laboratories.  
Animals  
 Adults male rats weighing between 152-167g and albino mice weighing between 25-34g 
(For acute toxicity study) were maintained in a well ventilated animal house under standard 
condition of humidity, temperature and a constant 12 hour light:12 hour dark lighting schedule. 
The animals were housed in clear polypropylene cages. The animals were maintained with 
standard pellet feed (Sai Durga Feeds and Foods, Bangalore, India) and water ad libitum. The 
health, normal behaviour and reproductive status of the animals were assessed and only healthy 
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animals were selected for the experiment. All experimental procedures described were reviewed 
and approved by the Institutional Animal Ethical Committee. 
(XIII/VELS/PCOL/27/2000/CPCSEA/IAEC/08.08.2012). 
Drug Stock solution  
 The powdered form of Isabgol Chooranam was mixed uniformly in 2% CMC and made 
into uniform suspension to achieve 200mg/ml as main stock solution and used in this study. 
Acute oral toxicity study  
 The acute oral toxicity study was carried out as per the guidelines set by Organization for 
Economic Co-operation and Development (OECD), revised draft guidelines 425 (Up and Down 
method) received from Committee for the Purpose of Control and Supervision of Experiments on 
Animals (CPCSEA). The test substances were administered in a single dose using a gastric 
intubation tube after fasting for 3 to 4 h.  
 Since there was no information on the substance to be tested, starting dose was 2000 
mg/kg body weight up to 5000 mg/kg body weight. Animals were observed initially after dosing 
at least once during the first 30 min, periodically during the first 24 h. In all cases death was 
observed within first 24h. Attention was also given to observations of behavioral changes and 
toxic symptoms like tremors, dyspnoea, writhing and convulsions etc. 
Evaluation Of Spermatogenic activity 
Animal grouping and Treatment  
 Twenty four adult male rats were randomly divided into four groups of six animals each. 
Group 1 (control) was administered with the vehicle (2% CMC suspension) while groups 2 and 3 
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were given suspension of Isabgol Chooranam at 50mg/kg and 100mg/kg. One rat was sacrificed 
to ensure the oligospermic induction at the beginning of the experiment ie after one week of 
TCDD injection. Two rats from each treatment group were randomly sacrificed after 14 days of 
Isabgol Chooranam administration while the remaining rats treatment were continued up to 28 
days. Treatment was done daily using oral dosing needle and twenty four hours after the last 
dose, blood was collected and the animals were sacrificed. All procedures regarding handling of 
the test animals were in accordance with the existing CPCSEA and IAEC guidelines. 
Induction of oligospermia by TCDD in rats 
 Initially, rats were injected with 40μg TCDD/kg i.p. At one week after TCDD exposure, a 
rat from each group was selected and tested for induction of oligospermia and after ensuring the 
oligospermic conditions the study was proceded furtherly.  
Blood sample and organ collection 
 After the last dosing of Isabgol Chooranam, all the animals were sacrificed by employing 
euthenesia procedure and the testes, epididymides, vas deferens, seminal vesicles and ventral 
prostates were identified, dissected out, blotted free of blood and cleared of connective tissue or 
fat. The organs were weighed immediately using a electronic digital balance. Blood samples 
were collected by retro-orbital puncture into anticoagulant pre-coated and also in plain sterile 
eppendorff tubes and allowed to clot at room temperature. Serum samples were separated by 
centrifugation at 3000 rpm for 10 min and stored at -20°C until testosterone assay. Anticoagulant 
added blood samples were used for the studying haematological parameters 
Sperm collection and Measurement of sperm parameters 
 The rats were anaesthetized with anesthetic ether and sacrificed after the last day of 
administration and weighed for the essential reproductive organs, such as testis, caudal 
epididymis, seminal vesicle and prostate glands. A scrotal incision was made to exteriorize the 
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testis and epididymides. The epididymides were carefully dissected out of the testes and blotted 
free of blood. To prepare sperm suspension, epididymal sperm were obtained by mincing cauda 
epididymis of each rat in pre-warmed beaker containing 2 ml of physiological saline (maintained 
at 37°C). Several incisions were made on it to allow sperm swim out.  
 Sperm characteristics were determined according to the standard protocols derived by the 
previous investigators in this research area. Sperm motility was also assessed immediately by 
counting both motile and immotile spermatozoa per unit area at the 40x magnification. Sperm 
count was done using the improved Neubauer’s haemocytometer under the light microscope at 
100x magnification. The count was expressed as million/ml of suspension. Sperm viability was 
assessed using eosin-nigrosin test. The percentages of unstained (alive) and stained (dead) 
spermatozoa were calculated by counting 100 spermatozoa randomly per sample. Morphological 
appearance of normal and abnormal spermatozoa was determined by examining stained smears 
under the oil immersion (100x) and their percentages were calculated. 
Testosterone Assay  
 Blood samples were spun at 2500rpm for 10 minutes in a table top centrifuge. The serum 
samples obtained were analyzed to determine the concentration of testosterone. The analysis was 
carried via the tube-based enzyme immunoassay method as described in the kit. 
Collection of tissues and histological analysis 
 The testes were collected and immediately fixed in Bouins fluid for 6 h and transferred to 
70% alcohol for histological processing. And following fixation of the testes from both control 
and test animals, tissue sections were processed by dehydration in 95% and absolute alcohol, 
153 
 
cleared in xylene and embedded in pure clean molten paraffin wax from which blocks of tissues 
were made for sectioning. Ribbon slices of about 5.0μm in thickness were made with the aid of a 
microtome and the sections picked with slides which were dried in oven. The slices were then 
stained with Haemotoxylin and Eosin, and then mounted using DPX onto a light microscope 
(magnification 40x) for histopathological and morphological changes. The changes observed 
were recorded and photomicrographs of the most prominent pathological alterations. 
Statistical Analysis 
 The results were analyzed by one-way analysis of variance using INSTAT version 3 for 
Windows. Significant differences within group variables were determined by Tukey's multiple 
comparison test. Results were considered significant at 5% level of probability (P < 0.05). The 
data were presented as mean ± SEM. 
RESULTS AND DISCUSSION  
 In the toxicity study, No specific signs of toxicity were seen in any of the animals except 
mild diarrhoea. Hence as per the guideline the one tenth & fifth of maximum tolerable doses 
were selected for further pharmacological study. However, most of the animals exhibited 
calmness; improve appetite for food and water and general well-being during the administration 
of Isabgol chooranam upto 500 and 1000mg/kg dose orally.  
 Male fertility requires the production by the testis of large numbers of normal 
spermatozoa through a complex process known as spermatogenesis. This process can be 
subdivided into three major steps: (i) the multiplication of spermatogonia by the process of 
mitosis; (ii) meiosis, which reduces the chromosome number from diploid to haploid and 
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commences with the entry of type B spermatogonia into the prophase of the first meiotic 
division. These cells, now called primary spermatocytes, divide to form secondary 
spermatocytes, and then divide again to form round spermatids; (iii) the successful 
transformation of the round spermatid into the complex structure of the spermatozoon, this phase 
being called spermiogenesis.  
 Each of these steps represents a key element in the spermatogenic process. Defects which 
occur in any of them can result in the failure of the entire process and lead to the production of 
defective spermatozoa and reduction or absence of sperm production. It is therefore essential that 
our understanding of these processes is expanded to provide information concerning the 
regulatory mechanisms. Oral administration of the Isabgol chooranam for four weeks showed 
that the body weights increased significantly (P < 0.05) from 164.20 ± 2.06 and 188.60 ± 1.33 to 
168.36 ± 1.86 and 184.52 ± 2.64, respectively. Significant increases (P< 0.01) in weights of testes, 
epididymides, ventral prostrate, seminal vesicles and vas deferens were observed in the treated 
groups compared with the control. 
 The sperm count was significantly (P< 0.01) higher in test drug Isabgol chooranam groups than 
the control in a dose related manner. In addition, the sperm motility and morphology of the test groups 
were also significantly (P<0.01) higher than the control. Furthermore, the percentages of abnormal sperm 
cells in treatment groups were reduced compared to the oligospermic control but it was statistically not 
significant. Similarly, Significant (P>0.01) increase in testosterone level of the treated group 
compared to control. Moreover, the low dose testosterone level was also significantly different 
from the control. TCDD and its related congeners have been shown to act as developmental and 
reproductive toxicants, which reduce testicular and accessory sex organ weights, alter testicular 
morphology, and decrease sperm production. In the control group, histopathologic examinations 
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of seminiferous tubules showed the usual arrangement of Leydig's cell, Sertoli cells, and 
intracellular spaces.  
 However, in TCDD-treated rats, cell differentiation, including that of spermatogonia, 
tended to be lower than in controls, maturation levels of spermatocytes and spermatids were also 
lower. In TCDD treated animals, all sperm developmental stages had almost completely returned 
to the control level, and sperm development was higher than in TCDD treated animals. 
Significant differences were found in the mean number of RBC and Hb level in Isabgol 
chooranam treated rats compared to control. But, a significant decrease in levels of blood sugar, 
serum cholesterol and serum phospholipids in the rats treated with Isabgol chooranam at the both 
dose levels were observed when compared to control. The result indicates that Isabgol 
chooranam affects testicle of rats, its increase the weight of this organs, there are significant 
increase in sperm cells concentration, on the other hand, increased sperm cell count but 
percentage of motile sperms was observed in only higher dose group animals.  
 Isabgol chooranam gave significant increase of the testicle mass. The round spermatid, 
which arises from the second meiotic division, undergoes a series of complex cytological events 
which transform it into the spermatozoon. This process consists of (i) nuclear condensation and 
movement of the nucleus to the periphery of the cell; (ii) formation of a modified lysosome 
known as the acrosome, which becomes attached to the surface of the nucleus in opposition to 
the cell membrane; (iii) flagellar formation which includes the development of a core of 
microtubules, the axoneme, which arises from one of the centrioles of the round spermatid.  
 In the Isabgol chooranam treated groups, there was a significant excess in the number of 
primary and secondary spermatocytes and round spermatids. The testis section of normal animals 
showed clear histological texture. The diameter of semniferous tubules varied within a range. 
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The tubules having maximum diameter, were not abundant and well within range. Sertoli cells 
had many cytoplasmic processes which were normal in size. Spermatozoa were embedded in the 
sertoli cells and showed normal cytoplasmic granulation. In the spermatogesis process, the 
formation of the axoneme, a series of equally spaced doublet microtubules surrounding two 
single central microtubules, occurs in the cytoplasm adjacent to the Golgi complex, but later in 
spermiogenesis, this structure becomes lodged at the abacrosomal pole of the nucleus through a 
complex articulation forming the neck of the spermatozoon.  
 Later in the formation of the tail, the axoneme is modified by the development of a series 
of nine electron dense fibres, termed the outer dense fibres, in the region of the mid-piece of the 
spermatozoon and distally by the formation of the fibrous sheath in the region of the principal 
piece; (iv) finally, following the completion of these events, the spermatid sheds a large part of 
its cytoplasm as the residual body which is phagocytosed by the Sertoli cell. Leydigs cells had 
normal nuclear size. Luminal part of the tubule were normal in number with bundles of 
spermatozoa.  
CONCLUSION 
 The results obtained in the present study strongly confirms the positive beneficial effects 
on male reproductive system by Increased number of spermatozoa in semniferous tubules and 
which is evident by increase in spermatogenic elements as compared to control. 
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 Table 1. Effect of Isabgol Chooranam on body weight of male albino rats. 
Parameter  Control IC 50 mg/kg IC 100 
mg/kg 
Initial Body Weight (g)  166.20 ± 1.88 164.20 ± 2.06 168.36 ± 
1.86 
Final Body Weight (g))  185.80 ± 1.91 188.60 ± 1.33 184.52 ± 
2.64 
nsP>0.05, values expressed as Mean±SEM, n=6 
 
Table 2. Effect of Isabgol Chooranam on reproductive organ weights of male albino rats 
Organ Control IC 50 mg/kg IC 100 
mg/kg 
Testes (g)  1. 94 ± 0.02 2.20 ± 0.01** 2.33 ± 
0.02** 
Epididymis (g)  0.33 ± 0.03 0.40 ± 0.01* 0.49 ± 
0.01** 
Ventral prostate (g)  0.27 ± 0.02 0.34 ± 0.05 0.42 ± 
0.01** 
Seminal vesicle (g)  0.48 ± 0.03 0.50 ± 0.01 0.60 ± 
0.01** 
Vas deferens (g)  0.13 ± 0.02 0.14 ± 0.02 0.14 ± 0.01 
*P<0.05; **P<0.01, values expressed as Mean±SEM, n=6 
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Table 3. Effect of Isabgol Chooranam on hematological and biochemical parameters in male 
rats after 28days of treatment. 
Parameters Control IC 50mg/kg IC 100mg/kg 
Hemoglobin (gm %) 12.44± 0.32 12.94±0.13  13.83± 0.22**  
RBC (million/cu.mm) 5.57± 0.04 5.72± 0.03*  5.76± 0.03**  
WBC (X103/cu.mm) 4.34± 0.56 4.47±0.36  4.53± 0.82  
Blood sugar (mg/dL) 78.03± 1.61 65.34± 2.72  63.33± 5.81*  
Blood urea (mg/dL) 31.72± 2.52 31.03±3.15  33.04± 3.03  
S.Cholesterol (mg/dL) 83.02± 0.54 69.07± 1.04**  63.03± 4.31**  
S. phospholipids (mg/L) 79.04± 0.63 74.08± 0.43** 72.02± 0.53**  
S. protein (mg/dL) 7.86± 0.16 8.21±0.64  8.43± 0.39  
*P<0.05; **P<0.01, values expressed as Mean±SEM, n=6 
Table 4: Effects of Isabgol Chooranam on sperm count, motility, viability and abnormal 
morphology after 14 days treatment. 
Groups Count (106/ml) Motility (%) Viability (%) Abnormal 
Morphology 
Control 8.10 ±0.28 85.40±1.07 96.00 ±1.52 2.18 ±0.38 
IC 50mg/kg 8.73±0.62 83.10±2.14 95.20 ±1.77 2.23 ±0.24 
IC 100mg/kg 9.21±0.37* 92.70±1.18** 95.70 ±1.45 2.17 ±0.37 
**P<0.01, values expressed as Mean±SEM, n=6 
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Table 5: Effects of Isabgol Chooranam on sperm count, motility, viability and abnormal 
morphology after 28 days treatment 
Groups Count (106/ml) Motility (%) Viability (%) Abnormal 
Morphology 
Control 8.17±0.25 84.60±1.31 93.80 ±1.91 2.43 ±0.41 
IC 50mg/kg 9.36±0.28* 89.40±2.53 95.37 ±2.21 2.48 ±0.26 
IC 100mg/kg 9.53±0.42* 92.50±1.84* 95.62 ±1.87 2.72 ±0.28 
*P<0.05, values expressed as Mean±SEM, n=6 
 
 
Table 6: Effects of Isabgol Chooranam on Testosterone level after 28 days treatment 
Groups Testosterone level 
(ng/ml) 
Control 0.012±0.018 
IC 50mg/kg 0.015±0.014** 
IC 100mg/kg 0.018±0.017** 
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HISTOPATHOLOGY OF PHARMACOLOGICAL STUDY 
Drug name: isabgol chooranam 
                      
control 
Normal                   
50 mg             
 100 mg          
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Bio statistical analysis 
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BIOSTATISTICAL ANALYSIS 
Effect of Isabgol Chooranam on Sperm Count in human subjects 
S.No Sperm  Count(million/cumm) 
Before Treatment After Treatment 
1 42 70 
2 25 48 
3 17 25 
4 19 59 
5 9 45 
6 67 70 
7 15 45 
8 35 50 
9 60 85 
10 12 16 
11 2 45 
12 50 68 
13 45 70 
14 15 45 
15 59 75 
16 25 50 
17 9 56 
18 20 30 
19 18 20 
20 70 75 
Software: spss17 version 
Variables: Sperm Count (millions/cu mm) – before treatment, after treatment 
Number of cases: 20 
Test: Paired t test 
Confidence Interval: 95% 
Correlation coefficient (r): 0.774 
Before and after treatment mean difference: 21.65±13.75 (millions/cu mm)  
P Value (2 tailed): p<0.01. 
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Inference:  
The p value is significant (p<0.01).  So the treatment was significantly improving 
the Sperm  count (millions/cu mm). 
Treatment for Aan Maladu 
The most popular statistical tool, namely, Fisher’s Exact Test analysis has been 
employed to analyses the effectiveness with the help of a hypothesis. 
Hypothesis 
There is no reducing symptoms among the patients for the treatment of Aan 
Maladu. 
 
 
Symptoms 
Number of Cases 
Reduced Not Reduced 
Premature ejaculation and 
Erectile dysfunction  
4 
66.7% 
2 
33.3% 
Premature ejaculation and 
Nocturnal Emission 
4 
66.7% 
2 
33.3% 
Nocturnal Emission  3 
100% 
0 
0% 
Software: spss17 version 
Number of cases: 15 
Test: Fisher’s Exact test 
Confidence Interval: 95% 
Result: 
P Value (2 tailed): p<0.05  
Inference:  Since the p value is significant (<o.o5), The hypothesis is not accepted. So 
there is significant reduced symptoms among the patients for the treatment of Aan 
Maladu. Hence it is concluded that the treatment was effective and significant. 
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Consent form 
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CONSENT FORM 
          I certify that I have disclosed all the details about the study in the terms readily 
understood by the patient.  
 
DATE :                                                                        SIGNATURE  
                                                                                     NAME 
CONSENT BY THE PATIENT 
 
           I have been informed to my satisfaction by the attending physician for the 
purpose of the clinical trial and the nature of the drug treatment and follow up including 
the lab investigation to be performed to monitor and safeguard my body functions. 
  
           I am aware of my right to opt out of the trial at any time during  
 the course of the trial without having to give reasons for doing so. 
 
           I ,exercising my free power of choice, here by  give my consent to be included as a 
subject in the clinical trial of  ISABGOL  CHOORANAM  for the treatment of  AAN 
MALADU. 
 
 
 DATE:                                                                                       SIGNATURE   
                                                                                                    NAME      
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§¿¡Â¡Ç¢Â¢ý ´ôÒ¾ø ÀÊÅõ 
 
 
           ¾¢Õ. ___________________________¬¸¢Â ¿¡ý ___________ÅÂÐ,         
(___________________________________________________________
_________________________________________________________, 
Åº¢ìÌõ þ¼õ) ±ý ÍÂ ¿¢¨É×¼ý ±Ø¾¢ì ¦¸¡ÎìÌõ ´ôÒ¾ø ÀÊÅõ. 
 
          ¿¡ý ¬ñ ÁÄÎ (¬ñ¨Á Ì¨È×) ±ýÛõ §¿¡Â¡ø À¡¾¢ì¸ôÀðÎ 
¦ºý¨É,«ÃÍ º¢ò¾ ÁÕòÐÅ ¸øæ¡¢Â¢ø  (þ¼õ: «È¢»÷ «ñ½¡ þó¾¢Â 
ÁÕòÐÅÁ¨É, «ÕõÀ¡ì¸õ, ¦ºý¨É-106.) ¿¼ò¾ôÀÎõ º¢ò¾ ÁÕòÐÅ 
¬Ã¡öîº¢ ãÄõ º¢¸¢î¨º ¦ÀÈ ±ý ÍÂ ¿¢¨É×¼ý ÓØºõÁ¾ò¨¾Ôõ 
¦¾¡¢Å¢òÐì¦¸¡û¸¢§Èý. 
 
          þó¾ ¬Ã¡öîº¢Â¢ý §¿¡ì¸õ, ÁÕòÐÅõ ¦ºöÔõ Ó¨È, ¦¾¡¼÷¸ñ¸¡½¢ôÒ 
ÁüÚõ ±ý ¯¼ø¿Äõ ÌÈ¢ò¾ ÁÕòÐÅ À¡¢§º¡¾¨É¸¨Çô ÀüÈ¢Â Å¢¡¢Å¡É 
Å¢Çì¸õ ±ÉìÌ ÁÕòÐÅõ ¦ºöÔõ ÁÕòÐÅ÷ ãÄõ ¦¾Ç¢×ÀÎò¾ôÀðÎûÇÐ. 
þó¾ ¬Ã¡öîº¢Â¢ø ÀíÌ¦¸¡ûÙõ ±ý ºõÁ¾ò¾¢üÌ Â¡Õ¨¼Â ¿¢÷Àó¾Óõ 
¸¡Ã½Á¢ø¨Ä ±ýÀ¨¾ ¦¾¡¢Å¢òÐì¦¸¡û¸¢§Èý. 
 
 
 
 
þôÀÊìÌ, 
 
 
¦ÀÂ÷     : 
Ó¸Å¡¢  : 
¿¡û       
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Case sheet proforma 
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CASE SHEET  
POST GRADUATE DEPARTMENT - BRANCH-I 
 (POTHU) MARUTHUVAM  
GOVT. SIDDHA MEDICAL COLLEGE & ANNA HOSPITAL, CHENNAI-106. 
CASE SHEET PROFORMA FOR “AAN MALADU” 
WARD NO. : NATIONALITY : 
I.P. NO : RELIGION : 
BED NO : OCCUPATION : 
NAME : INCOME : 
AGE : D.O.A : 
SEX : D.O.D                            : 
PERMANENT ADDRESS :  
  DIAGNOSIS : 
 
TEMPORARY ADDRESS:  
 
Govt. Siddha Medical College & 
Anna Hospital, Chennai – 106.                            MEDICAL OFFICER : 
 
 
COMPLAINTS AND DURATION : 
 
 
 
HISTORY OF PRESENT ILLNESS: 
 
 
HISTORY OF PAST ILLNESS :    Yes          No 
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Mumps / Orchitis    :     
Prostatitis     :   
STD      :     
Diabetes mellitus    :     
Hypertension     :   
Cardiac diseases    :   
 
Surgical history      :   Yes          No 
Hydrocele     :         
Varicocele     :       
Blockage of vas    :     
Hernia     :     
Obstruction of ejaculatory duct  :     
Trauma     :     
 
 
PERSONAL HISTORY & HABITS : 
 
A. Diet          : Veg.   Non veg.    
B. Marital status    : single               married 
C. Duration of marriage (yr) : 
D. Consanguineous  : Yes             No   
E. Sexual history 
F. Erectile function   : Normal        or  Affected 
G. Ejaculatory effect   : Normal        or   Affected 
H. Frequency of intercourse (per/month)    : 
I. Frequency of masturbation (per/month) : 
J. Lubricants   : Yes          No   
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K. Nocturnal Emission  : Yes          No   
L. Painful coitus   : Yes             No   
M. Burning micturition  : Yes             No   
N. Spermaturia   : Yes              No   
O. Emotional stress  : Yes          No 
P. Addiction    : Yes   No 
a. If yes specify :_____________________________________________ 
Q. Bowel habit    : Regular  Constipation 
R. Sleep     : Good                     Disturbed                Insomnia 
S. Presence of anxiety   : Yes   No 
 
FAMILY HISTORY: 
 
• No. of abortions his wife had Yes   No        
• Cardiovascular disease   Yes  No 
• Tuberculosis   Yes  No 
• Others   Yes  No 
 
If yes specify :    
HISTORY OF CONGENITAL ANOMALIES :  Yes   No 
Cryptorchidism         
Hypospadias          
DRUG HISTORY           :      Yes   No 
Steroids           
Anti – depressants                                                       
                                . 
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GENERAL EXAMINATION: 
1. Physical build :        lean                    normal                   obese  
2. Body weight  : 
3. Temperature  : 
4. Pulse rate : 
5. Heart rate : 
6. Respiratory rate : 
7. Blood pressure  : 
8.  Pallor   : 
9. Cyanosis  : 
10. Jaundice : 
11. Clubbing  : 
12. Pedal oedema : 
13. Lymphadenopathy   : 
14. Acanthosis nigricans : 
15. Hirsutiom :  
 
EXAMINATION OF VITAL ORGANS 
• CVS   : Normal Abnormal 
o If abnormal , details_______________________________________ 
• CNS  : Normal Abnormal 
o If abnormal , details_______________________________________ 
• Respiratory system     : Normal Abnormal 
o If abnormal , details_______________________________________ 
 
• Digestive system : Normal Abnormal 
o If abnormal , details_______________________________________ 
• Urogenital  system : Normal Abnormal 
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o If abnormal , details_______________________________________ 
 
Local  examination 
• INSPECTION   :  Yes   No 
• Hydrocele  :     
• Varicocele  :     
• Inguinal Hernia :     
• Filarial Scrotum :     
• Both testicles present in scrotum : 
• PALPATION:  
• Size and Consistency of testicles :  Normal                   Abnormal   
  
SIDDHA ASPECTS 
Yaakai (udal nilai)      Mukkunam  
1. Vatham        1. Sathuva gunam 
2. Pitham       2. Raasatha gunam  
3. Kapham       3. Thamo gunam 
4. Kalappu 
 
PARUVA KAALAM (SEASONS)   
1. Kaar Kaalam (Aavani-Puratasi) Aug-sept.      
2. Koothir Kaalam (Iypasi-Karthigai) Oct-Nov.  
3. Munpani  Kaalam (Maargazhi-Thai) Dec-Jan 
4. Elavenil Kaalam (Chithirai-Vaikasi) Apr-May  
5. Mudhuvenil  Kaalam (Aani-Aadi) Jun-Jul 
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NILAM (PLACES) 
               1.Kurinchi (Hills  Areas) 
 2.Mullai (Forest Areas) 
 3.Marudham (Fertile Areas) 
 4.Neithal (Sea Areas) 
 5.Paalai (Desert Areas) 
 
IYAMPORIGAL/PULANGAL  
  
1. Mei  (Sensation)  : 
2. Vaai (Taste)  : 
3. Kann  (Vision)  : 
4. Mooku(Smell)  : 
5. Sevi (Hearing) : 
6. Sevi (Hearing)                                                 : 
KANMENTHIRIYAM / KANMAVIDAYAM 
 1.Kai [Koduthal] : 
 2.Kaal [Nadathal] : 
 3.Vaai [Pesal] : 
 4.Eruvai [Malam Kazhithal] :  
 5.Karuvai [Aananthithal] : 
MUMMALAM 
1. Malam       
2. Moothiram 
3. Viyaravai 
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UYIR THATHUKKAL:       Vatham: 
1. Pranan :  6.  Naagan: 
2. Abanan :  7.  Koorman: 
3. Viyanan :  8.  Kirukaran: 
4. Udhanan :  9.  Devadathan: 
5. Samanan:  10. Dhananjeyan: 
 
PITHAM:   KAPHAM: 
1. Anal Pitham:  1.  Avalambagam: 
2. Ranjaga Pitham:   2.  Kiledagam: 
3. Saadhaga Pitham:   3.  Podhagam: 
4. Aalosaga Pitham :  4.  Tharpagam: 
1. Prasaga Pitham:  5.  Santhigam: 
UDAL THATHUKKAL: 
1. Saaram : 
2. Senneer :  
3. Oon : 
4. Kozhuppu : 
5. Enbu : 
6. Moolai : 
7. Sukkilam                    : 
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ENVAGAI THERVU: 
1. Naa -  
2. Niram              - 
3. Mozhi -  
4. Vizhi -  
5. Sparisam         - 
6. Malam  
a. Niram 
b. Nurai 
c. Erugal   
d. Elagal 
7. Moothiram 
a.  Neerkuri  
1.  Niram 
2. Edai 
3. Manam 
4. Nurai 
5.  Enjal 
b. Neikuri 
8. Naadi 
  
Neikuri examination: 
             Before treatment:  After treatment: 
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SIGNS AND SYMPTOMS : 
 
Sl.No 
 
Clinical Features 
 
Before Treatment 
 
 
During Treatment of every 15 days 
1st 2nd 3rd 4th 5th 6th 7th 8th 
  1 Premature 
ejaculation 
 
         
  2 Erectile 
Dysfunction 
         
  3 Painful coitus 
 
         
  4 Nocturnal emission          
  5 Burning micturition          
 
 
LABORTORY INVESTIGATIONS:                                      
    BT                            AT 
1.Blood  Tc 
   Dc 
   ESR 
   Hb 
   Bl-sugar (R) 
   Bl.Urea 
   Sr.Cholesterol 
   Sr.Creatinine 
               VDRL test 
2.Urine - albumin 3.Motion-   Ova 
                    Sug                   Cyst 
   Dep: 
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 4.Semen Analysis 
Semen analysis          Before Treatment After Treatment 
 
Count 
 
  
Volume(ml) 
 
  
Viscosity 
 
  
Liquification time 
 
  
Sperm concentration(millions/cu mm) 
 
  
Motility(%) 
 
  
Active motile(%) 
 
  
Sluggish motile(%) 
 
  
Morphology 
Other Investigations 
 
TRAIL DRUG:  ISABGOL CHOORANAM 
Dose:  1 gm (bd)  
Anubanam: milk 
Duration of treatment: 90 days 
Pathiam (Do’s and Don’ts) : 
Prognosis at the end of the treatment : 
 
Medical Officer  Signature:  H.O.D  
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